Figures
Abstract
The spirochete Borrelia burgdorferi causes Lyme disease. In some patients, an excessive, dysregulated proinflammatory immune response can develop in joints leading to persistent arthritis even after antibiotic therapy. In such patients, persistence of antigenic B. burgdorferi peptidoglycan (PGBb) fragments within joint tissues may contribute to immunopathogenesis pre- and post-antibiotic treatment. In live B. burgdorferi cells, the outer membrane shields the polymeric PGBb sacculus from exposure to the immune system. However, unlike most diderm bacteria, B. burgdorferi releases PGBb turnover products into its environment due to the absence of recycling activity. In this study, we identified the released PGBb fragments using a mass spectrometry-based approach. By characterizing the l,d-carboxypeptidase activity of B. burgdorferi protein BB0605 (renamed DacA), we found that PGBb turnover largely occurs at sites of PGBb synthesis. In parallel, we demonstrated that the lytic transglycosylase activity associated with BB0259 (renamed MltS) releases PGBb fragments with 1,6-anhydro bond on their N-acetylmuramyl residues. Stimulation of human cell lines with various synthetic PGBb fragments revealed that 1,6-anhydromuramyl-containing PGBb fragments are poor inducers of a NOD2-dependent immune response relative to their hydrated counterparts found in the polymeric PGBb isolated from dead bacteria. We also showed that the activity of the human N-acetylmuramyl-l-alanine amidase PGLYRP2, which reduces the immunogenicity of PGBb material, is low in joint (synovial) fluids relative to serum. Altogether, our findings suggest that MltS activity helps B. burgdorferi evade PG-based immune detection by NOD2 during growth despite shedding PGBb fragments and that PGBb-induced immunopathology likely results from host sensing of PGBb material from dead (lysed) spirochetes. Additionally, our results suggest the possibility that natural variation in PGLYRP2 activity may contribute to differences in susceptibility to PG-induced inflammation across tissues and individuals.
Author summary
During bacterial infection, the presence of peptidoglycan—a polymeric element of bacterial cell walls—triggers a host inflammatory response. Although generally protective during acute phases, inflammation, when chronic, can contribute to disease development. Recent work has suggested that the persistence of pro-inflammatory peptidoglycan derived from the Lyme disease spirochete Borrelia burgdorferi in joints may contribute to persistent arthritis in some patients despite appropriate antibiotic therapy. Interestingly, B. burgdorferi sheds peptidoglycan turnover products into the environment during growth. Here, we show that these shed products from live spirochetes are poor effectors of an immune response by the human NOD2 immune receptor due to the formation of an anhydro bond on the N-acetyl-muramic residue during peptidoglycan hydrolysis by a B. burgdorferi lytic transglycosylase. We also show that human N-acetylmuramyl-l-alanine amidase activity, which abrogates the NOD2-dependent response to the immunogenic peptidoglycan isolated from lysed B. burgdorferi cells, is low in human joint fluids relative to serum. Based on our findings, we propose that immunopathogenesis by peptidoglycan material more likely derives from lysed spirochetes (killed by an immune attack or antibiotics) than live ones and that the level of human peptidoglycan hydrolytic enzymes across tissues and individuals influences susceptibility to chronic inflammation.
Citation: McCausland JW, Kloos ZA, Irnov I, Sonnert ND, Zhou J, Putnik R, et al. (2025) Bacterial and host enzymes modulate the pro-inflammatory response elicited by the peptidoglycan of Lyme disease agent Borrelia burgdorferi. PLoS Pathog 21(7): e1013324. https://doi.org/10.1371/journal.ppat.1013324
Editor: John M. Leong, Tufts Univ School of Medicine, UNITED STATES OF AMERICA
Received: January 7, 2025; Accepted: June 23, 2025; Published: July 7, 2025
Copyright: © 2025 McCausland et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Raw MS data are available in the GlycoPOST repository (PMID 33174597) under accession numbers GPST000537 and GPST000595. Raw microscopy images are available in the BioImage Archive (PMID 35189131) under the accession number S-BIAD1573. All other datasets and code for image and MS data analysis can be downloaded from the Jacobs-Wagner lab Github site (https://github.com/JacobsWagnerLab/published/tree/master/McCausland_et_al_2025).
Funding: This research was supported in part by funding from the James D. Jamieson and Family M.D.-Ph.D. Scholarship Fund at Yale University (to Z.A.K), the Medical Scientist Training Grant T32 GM007205 from the National Institute of General Medical Sciences, National Institutes of Health (to Z.A.K), the Stanford Bio-X Interdisciplinary Initiatives Seed Grants Program (IIP) [R10-9] (to C.J.-W.), the National Institutes of Health (R01GM138599 to C.L.G), and the Younger Family (to C.J.-W.). C.J.-W. is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Lyme disease is the most prevalent and fastest-growing vector-borne disease in the United States and Northern Europe [1–4]. It is caused by Borrelia burgdorferi, a spirochete that is transmitted by Ixodes ticks. This pathogen circulates in nature through transmission and persistence in vertebrate reservoirs including rodents, birds, and lizards [5]. Infection in humans is often apparent by the presence of a slowly expanding skin lesion at the site of the tick bite. In the absence of appropriate diagnosis and antibiotic therapy, B. burgdorferi can disseminate widely to extracutaneous tissues, producing multisystem clinical manifestations such as flu-like symptoms, meningitis, carditis, and often arthritis, a late disease manifestation.
B. burgdorferi is not known to produce toxins that damage host cells. Rather, clinical symptomatology is caused by the host inflammatory response [6]. In some patients with Lyme arthritis, an exaggerated, dysregulated proinflammatory immune response develops, which can lead to persistent arthritis even after appropriate antibiotic therapy. This response is often referred to as postinfectious, antibiotic-refractory Lyme arthritis. The consequences in joint (synovial) tissues, which are the target of the immune response, include vascular damage, autoimmune and cytotoxic reactions, and massive fibroblast proliferation and fibrosis [7]. What leads to the persistence of these symptoms is not well understood and likely involves multiple factors. We recently proposed peptidoglycan (PG) as one of these potential contributing factors [8]. PG, an essential component of bacterial cell walls and a well-known immunogen [9], is made of glycan strands of repeating disaccharide-peptide units that form a crosslinked polymeric structure (known as a sacculus) around the bacterial cytoplasmic membrane. B. burgdorferi PG (PGBb) has been demonstrated to be immunogenic, as purified PGBb sacculi induce an inflammatory response in mammalian cell cultures, C3H/HeJ mice, and humans [8,10]. Remarkably, evidence suggests that PGBb material can persist in the synovial fluids of Lyme arthritis patients, even months to a year after antibiotic treatment [8]. Furthermore, these patients have a high level of anti-PGBb IgG antibodies detected within the synovial fluid of the affected joint [8]. In the host, PGBb is detected by the innate immune receptor NOD2 [8]. Interestingly, the transcript level of NOD2 transcripts is elevated in the inflamed synovial tissues of Lyme arthritis patients long after the resolution of the acute infection [11]. In addition, mouse and in vitro cell experiments have linked NOD2 to proinflammatory cytokine production and immune tolerance during B. burgdorferi infection [12,13]. Altogether, these observations have led to the hypothesis that the persistence of residual PGBb contributes to the pathogenesis of Lyme arthritis [8] by acting as an adjuvant that stimulates chronic inflammation and/or by bolstering T cell proinflammatory immunoreactivity with autoantigens [14].
In live B. burgdorferi cells, the outer membrane shields the PGBb sacculus from immune detection by the host. However, two potential sources of PGBb exposure to the immune system have been proposed [8]. First, when B. burgdorferi cells die due to the harsh conditions in the host (e.g., innate immunity or antibiotic treatment), they lyse, releasing PGBb material to the surrounding environment. Second, live spirochetes degrade ~40% of their PG during growth but, unlike Escherichia coli and many other diderm bacteria [15], B. burgdorferi does not recycle PG turnover products during growth [8]. As a result, growing B. burgdorferi cells continuously release PGBb fragments into the culture supernatant, possibly through diffusion across the outer membrane through porins.
These observations raise a number of questions. Do PGBb materials released from both dead and live spirochetes contribute to immunopathogenesis? Or is one source more likely to contribute than the other? If live B. burgdorferi does indeed release PGBb fragments into the environment during growth, how does this pathogen evade PG-based immune recognition and eradication by the host? Could the PGBb material shed from live B. burgdorferi cells be chemically distinct from the immunogenic PGBb of dead cells to avoid detection? Do PG hydrolases produced by B. burgdorferi and/or the host play a role in modulating immune response and pathogenesis? We sought to address these questions by characterizing the PGBb fragments released by live B. burgdorferi cells during growth and by identifying both bacterial and host factors that modulate PGBb-induced immune responses.
Results
Multiple B. burgdorferi strains shed peptidoglycan fragments of the same composition during growth
During growth, new disaccharide-peptides are incorporated into the existing PG sacculus. In B. burgdorferi, these PG precursors consist of N-acetyl-glucosamine (GlcNAc) and N-acetyl-muramic acid (MurNAc) linked to a peptide chain made of l-alanine (l-Ala), d-glutamic acid (d-Glu), l-ornithine (l-Orn), and two d-alanine residues (d-Ala), with l-Orn being connected to a single glycine (Gly) [8,10]. The growing PG polymer is then crosslinked, remodeled, and trimmed by PG enzymes, leading to the mature sacculus illustrated in Fig 1A [8].
A. Schematic showing the chemical composition of the B. burgdorferi peptidoglycan (PGBb) and its location between the cytoplasmic and outer membranes. B. Workflow of the experimental approach: the supernatants (‘Sup’) of B. burgdorferi cultures vs. medium-only controls (‘BSK’) were analyzed by LC-MS to identify enriched mass features. Any enriched hits were compared against a mass library of potential PGBb monomers and dimers from which five candidate PGBb fragments were identified. C. Volcano plot of [M+H] features either enriched or depleted compared to medium only. Dark gray dots are mass features that are below the false discovery rate threshold of p < 0.05 and are greater than a fold-change of 3. Mass features that correspond to five candidate PGBb fragment candidates are indicated in red and labeled with the corresponding [M+H]+ values. The asterisk marks the PGBb fragment candidate with the same [M+H]+ value (992), but with three differently enriched isomers. The datapoint for one of these isomers overlaps with a datapoint for another putative PGBb fragment ([M+H]+ = 532). D. Table of predicted (calculated from our theoretical PGBb fragment library, S1 Dataset) and detected masses of the five candidate PGBb fragments identified in the culture supernatants. E. Individual extracted ion chromatograms (EICs) showing the enrichment of the PGBb fragment species in the supernatant (Sup) relative to medium-only control (BSK). The asterisks show the three peaks corresponding to isomeric forms of PGBb fragment #3.
For this study, our first goal was to identify the major species of PGBb fragments that B. burgdorferi releases into its culture medium during growth. This was a non-trivial task, as laboratory cultures of B. burgdorferi require the use of a highly complex, undefined medium (e.g., BSK-II, which includes GlcNAc, glucose, CMRL medium, bovine serum albumin, rabbit serum, neopeptone, and yeastolate). To find rare PGBb fragments in a complex mixture of other molecules in BSK-II, we developed a pipeline in which mass features enriched in the culture supernatant over the cell-free growth medium are screened against a library of simulated PGBb fragment masses (Fig 1B, see Materials and Methods). Briefly, replicates of a clonal derivative of the B. burgdorferi type strain B31 (B31 IR) were grown in BSK-II to late exponential phase (i.e., density of ~5 x 107 cells/mL). Culture supernatants (‘Sup’) were then harvested and analyzed by liquid chromatography (LC) coupled to mass spectrometry (MS) in comparison to the cell-free medium-only control (‘BSK’).
We found that over 2000 mass features displayed a significant (p < 0.01, Welch t-test and FDR-corrected) difference abundance (at least three-fold) between culture supernatants and the BSK-II control (Fig 1C). Most of these mass features were underrepresented in the culture supernatants, as expected from nutrients consumed from the BSK-II medium during B. burgdorferi growth. Of greater interest were the 270 mass features found to be enriched in the culture supernatants. To examine whether any of them might correspond to PGBb fragments, we computationally generated a mass library representing more than 700 permutations of possible PGBb monomers and dimers (S1 Dataset and Fig 1B). Of the compounds that were undetectable in medium-only samples but present in culture supernatants, we found five molecules with masses corresponding to predicted monomeric PGBb species (Fig 1D and S1 Table, PG fragment species #1–5). One of them ([M+H]+ = 992) was represented three times in Fig 1C due to the presence of isomers (marked by asterisks in Fig 1E). Two of the identified putative PGBb fragment candidates were peptide stem variants of the PGBb: one with Gly linked to Orn, l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala (PG fragment #1), and the other without Gly, l-Ala-d-Glu-l-Orn-d-Ala-d-Ala (PG fragment #2). Two others were disaccharide-peptides: GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala (PG fragment #3) and GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly) (PG fragment #4). The remaining molecule consisted of the disaccharide moiety alone: GlcNAc-AnhMurNAc (PG fragment #5). All three sugar-containing candidates (PG fragments #3–5) were found to harbor MurNAc modified with an intramolecular 1,6-anhydro bond (Anh). This anhydro bond corresponds to the loss of a water molecule (18 Da). Plotting the extracted ion counts of the identified molecules demonstrated that all five PG fragment candidates were in quantities below the level of detection in the BSK II-only control, yet present in each of the three replicates culture supernatant samples analyzed (Fig 1E). The identity of each candidate was confirmed by tandem MS fragmentation (S1–S5 Figs).
We found that these PGBb monomers accumulated during B. burgdorferi growth in BSK-II medium (Fig 2A and 2B), consistent with these molecules being the products of PGBb metabolism. This was observed not only for the strain B31 IR, our clonal derivative of the type strain B31 MI, but also for other B. burgdorferi strains, including K2, a clonal derivative of B31 MI amenable for cloning [16,17], the infectious patient isolate strain 297 [18], and the infectious tick isolate N40 [19]. We verified that B31 IR, K2, and N40 strains all have the expected complement of plasmids originally described for each strain (S6A–S6C Fig) [17,20]. Our strain 297 lacks cp32–6 and cp32–9 (S6D Fig) compared to the plasmid set previously described [20]. We expect this strain to remain infectious as recent work has shown that cp32 plasmids are dispensable for infectivity in mice [21]. A similar growth-dependent collection of PGBb fragments was found to accumulate in the culture medium of all four B. burgdorferi strains tested (Fig 2B).
A. Growth curves of four indicated B. burgdorferi strains. B. Plots showing the accumulation (increase in extracted ion count) of the indicated PGBb fragment species in culture supernatants over time. Strains B31 IR, K2, 297, and N40 were sampled once daily during normal growth starting at a density of 1x104 cells/mL. Three biological replicates are included for days 1, 4, and 7, while a single measurement was taken for days 2, 3, 5, and 15. The Grey shade shows the mean (µ) ± two standard deviations (2σ) for the background detection in the medium-only control (BSK).
BSK-II medium and one of its components, heat-inactivated rabbit serum, can possess residual peptidoglycan-hydrolytic activity
We noted that the levels of peptide- and disaccharide-only PGBb fragments continued to accumulate after the cultures reached stationary phase around day 7 (Fig 2B). In contrast, the levels of disaccharide-peptides often leveled off or decreased in these stationary phase cultures (Fig 2B). While these observations may reflect changes in PG enzymatic activities in stationary-phase B. burgdorferi cells, it also raised the possibility that the BSK-II medium itself may possess N-acetylmuramyl-l-alanine amidase activity that results in the cleavage of some shed disaccharide-peptides into their constituent parts (i.e., disaccharide- and peptide-only fragments). BSK-II growth medium contains rabbit serum at a final concentration of 6% (v/v), with standard heat inactivation of complement activity while preserving growth-promoting factors. Since rabbit serum has been reported to contain N-acetylmuramyl-l-alanine amidase activity [22], we reasoned that our heat-inactivated rabbit serum may still possess trace of amidase activity. If this were the case, incubation of purified PGBb sacculi in complete BSK-II medium or in 100% heat-inactivated rabbit serum alone would be expected to result in the liberation of peptide-only PG fragments. Indeed, as shown by LC-MS analysis (S7 Fig), we detected the accumulation of l-Ala-d-Glu-l-Orn(Gly) peptides, the prevalent peptide stem in the mature PGBb sacculus (Fig 1A) [8], in both BSK-II and heat-inactivated rabbit serum. These results suggest that at least a fraction of the disaccharide and peptide-only PGBb fragments found in the culture supernatant is generated by mammalian enzymes present in the BSK-II medium.
Peptidoglycan synthesis and turnover are largely coupled during B. burgdorferi growth
The prevalence of the peptide stem carrying a terminal d-Ala-d-Ala dimer among the PGBb fragments present in culture supernatants was surprising. d-Ala-d-Ala is predicted to be rare in the mature PGBb layer (Fig 1A) as it is not even detected in the chromatogram of muramidase-digested PGBb sacculi isolated from cells grown in vitro [8]. Instead, unlinked peptide stems in the mature PGBb are almost exclusively of the form l-Ala-d-Glu-l-Orn(Gly) (Fig 1A). This suggests that the larger l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala peptide stems present in PGBb precursor molecules are rapidly either crosslinked or trimmed by carboxypeptidases (CPases) to remove the terminal d-Ala residues and regulate the degree of crosslinking between glycan strands [23,24]. Accordingly, the PGBb sacculus of a B. burgdorferi mutant defective in CPase activity would be expected to contain a higher proportion of peptide stems with terminal d-Ala residues.
We obtained a B. burgdorferi mutant (strain T08TC493) with a Himar1 transposon insertion at position 300 downstream of the first codon of the bb0605 open reading frame, which is predicted to encode a CPase of 406 amino acids [25]. We purified PGBb sacculi from bb0605::Himar1 cells and compared their chemical composition to that of sacculi isolated from the B31-derived parent strain 5A18NP1 following enzymatic digestion of both sacculus preparations using mutanolysin, a muramidase that cleaves the β(1–4) glycosidic bond between MurNAc and GlcNAc. The total-ion-count profiles representing digested sacculi from bb0605::Himar1 and its parent differed considerably (Fig 3A). Note that each PGBb fragment typically eluted at more than one retention time, reflecting different isomeric forms. The extracted ion count profiles obtained for the parent strain revealed PG monomers primarily harboring peptide stems lacking d-Ala residues (variants i and ii in Fig 3B), consistent with the results of a previous PGBb digest analysis performed on another B. burgdorferi strain [8]. In contrast, bb0605::Himar1 sacculi demonstrated decreased abundance of such peptide stem variants (Fig 3B); instead, they were associated with a high proportion of PG monomers carrying longer peptide stems that contained d-Ala-d-Ala (variants iii and iv in Fig 3C). These data strongly suggest that BB0605 is an l,d-carboxypeptidase that prunes terminal d-Ala residues from PGBb peptide stems in wild-type cells. We propose this protein to be renamed d-Ala carboxypeptidase A (DacA) based on structural prediction comparison with an E. coli homolog of the same name (S8 Fig) [26].
A. Total ion chromatograms of parent (strain 5A18NP1) vs. bb0605::Himar1 (strain T08TC493) sacculi digested with mutanolysin. Relevant peaks are denoted with numbers corresponding to the most abundant PGBb fragment species. B. Plots showing the extracted ion count (EIC) of GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly) (top) and GlcNAc-MurNAc-l-Ala-d-Glu-l-Orn(Gly) (bottom) for the parent vs. bb0605::Himar1 strains as a function of their run time through the liquid chromatography column. C. Same as (B) but for GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala (top) and GlcNAc-MurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala (bottom). D. Representative fluorescent images of parent cells stained with HADA for 1 and 8 h. Cell outlines were generated by making a mask of the cell in the corresponding phase contrast image, dilating it five times, and creating a contour of the binary mask. Scale bar is 5 µm. E. Same as (D) except that bb0605::Himar1 cells are shown and that the HADA signal for parent cells are contrast-normalized to that of bb0605::Himar1 cells. The look up table on the right applies to images with the same time point. F. Mean linescan intensities of HADA staining in parent vs. bb0605::Himar1 cells. The shaded area represents the standard error of the mean (n = three biological replicates for each time point for which over 200 cells were analyzed per condition).
The LC-MS experiments with the bb0605::Himar1 mutant also allowed us to determine the retention time of PGBb monomers harboring terminal d-Ala-d-Ala and verify that sacculi of the parent strain do indeed contain a small amount of these monomeric subunits (inset, Fig 3C). This small amount of d-Ala-d-Ala-containing peptide stems likely correspond to PGBb precursor molecules newly incorporated into the existing sacculus (i.e., before crosslinking and processing). This is consistent with our previous work showing that zones of new PG synthesis in B. burgdorferi are marked by fluorescent d-Ala analogs such as 7-hydroxycoumarincarbonylamino-d-alanine (HADA) upon their substitution for native d-Ala at the fifth amino acid position of the peptide stem [27]. We reasoned that if the HADA signal previously observed in wild-type B. burgdorferi cells represents the low level of newly inserted d-Ala-d-Ala-containing peptide stems in the PGBb layer, this signal should increase considerably in the bb0605::Himar1 mutant cells. As we reported previously [27], the addition of HADA to parent cell cultures for 1 h resulted in preferential accumulation of HADA signal at midcell due to enriched PGBb growth at that site, with occasional polar enrichment derived from division (Fig 3D). We observed the same overall spatial pattern of HADA labeling in bb0605::Himar1 cells, but at a greater level, as shown qualitatively in images (Fig 3E) and by fluorescence signal quantification along the cell length (Fig 3F). This is consistent with an increased level of d-Ala-d-Ala-containing peptide stems in the PGBb layer in the absence of DacA activity. Increasing the time of HADA incorporation from 1 to 8 h (the latter approximating the generation time of B. burgdorferi) further increased the fluorescence signal intensity into the PGBb due to growth (Fig 3D–3F). Altogether, our data suggest that, in a wild-type context, a considerable fraction of PGBb fragments shed into the environment is derived from d-Ala-d-Ala-containing PGBb material that had just been incorporated, before the d-Ala are removed by DacA or cross-linking. This indicates that the degradation of the PG is tightly coupled in time and space with its synthesis in B. burgdorferi.
BB0259 (MltS) contributes to the shedding of AnhMurNAc-containing peptidoglycan monomers through lytic transglycosylase activity
Another characteristic of the released PG fragments we identified was that all three sugar-containing molecules contained AnhMurNAc. No corresponding molecules containing MurNAc residues in hydrated/reducing form (i.e., no anhydro bond) were detected in culture supernatants (S9 Fig). AnhMurNAc-containing PG fragments are the product of bacterial enzymes known as lytic transglycosylases (LTGases) [28]. These enzymes cleave the β(1,4)-glycosidic linkage between GlcNAc and MurNAc residues and, in the process, catalyze an intramolecular transglycosylation reaction that leads to the formation of an anhydro bond between C1 and C6 of MurNAc [28–31]. When these enzymes act on the polymeric PG, the anhydro bonds they introduced into the PG sacculus prevent the incorporation of another disaccharide-peptide, thereby controlling the average length of glycan strands within the sacculus [28,29,32–34]. Thus, AnhMurNac residues are found only at the end of glycan strands (Fig 1A) and are, as a consequence, found in low abundance in the PG layer relative to MurNAc residues. The activity of LTGases is also important for degrading large PG turnover products into small soluble fragments [35].
Based on sequence homology searches, B. burgdorferi has two putative LTGases [36]. One of them, encoded by the bb0259 gene, is required for the motility and wavy morphology of B. burgdorferi cells [36]. This putative LTGase has been proposed to degrade PGBb above the site of flagellar basal body insertion into the cytoplasmic membrane to allow flagellar filament assembly across the PGBb layer [36]. Based on gene deletion results, the other putative LTGase-encoding gene, bb0531, has no apparent effect on flagellar assembly, motility, or cell morphology [36]. Since the LTGase activity had not previously been demonstrated for either gene product, we obtained bb0259 and bb0531 knockout strains [36] and examined their ability to release AnhMurNAc-containing PG fragments into culture media relative to the parental strain. LC-MS revealed that the levels of all three AnhMurNAc-containing PG turnover products present in the culture supernatants of the parent strain were considerably lower in the supernatants of the ∆bb0259 cultures, but not in those of the Δbb0531 cultures (Fig 4). Furthermore, the levels of released AnhMurNAc-containing molecules were largely restored in the ∆bb0259 strain expressing wild-type bb0259 from a shuttle vector (Fig 4), indicating phenotypic complementation. These results provide compelling evidence that bb0259 encodes a bona fide LTGase that contributes to PG turnover and shedding in B. burgdorferi. Based on structural prediction, this B. burgdorferi LTGase shares similarity with the cytosolic E. coli Stl70 (S10 Fig). However, BB0259 differs from Stl70 by being anchored to the inner membrane [37]. Therefore, in consultation with Dr. Motaleb whose laboratory at East Carolina University generated the ∆bb0259 strain used in this study [36], we propose the bb0259 gene to be renamed mltS and its product, MltS, for “membrane-bound lytic transglycosylase in spirochetes.”
For all panels, the medium-only control (BSK) was compared to the culture supernatants of the following strains: parent (B31-A), ∆bb0531, ∆bb0259 and ∆bb0259 complemented by expression of bb0259 from the flgB promoter on a shuttle vector [36]. A. Plot showing the extracted ion counts (EIC) for GlcNAc-AnhMurNAc in the culture supernatants of the indicated strain. Dots represent data from three biological replicates, and the height of each bar represents the mean. Each EIC value was obtained by integrating the relevant peak for each PGBb fragment species. B. Same as (A) but for GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly) C. Same as (A) but for GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala.
The peptidoglycan monomers released during B. burgdorferi growth generate little to no NOD2-dependent inflammatory response in vitro
Our findings indicate that the PGBb fragments shed by live spirochetes during growth display chemical differences relative to the polymeric PGBb sacculus, which can become exposed when B. burgdorferi dies and lyses. How these chemical variations may affect the host immune response is not entirely clear. For instance, purified anhydromuramyl derivatives of MurNAc-peptides have been shown to be poor inducers of NOD2 [38,39]. On the other hand, the AnhMurNAc-containing PG fragment GlcNAc-AnhMurNAc-l-Ala-d-Glu shed by Neisseria species has been described as a NOD2 agonist [40].
To examine this in the context of B. burgdorferi pathogenesis, we used a panel of synthetic PGBb fragments (30 µM) with varying chemical features [41]. For simplicity, we will hereafter refer to PG fragments with both AnhMurNAc and peptide moieties as anhydromuropeptides to distinguish them from the muropeptides that have reducing MurNAc residues. Our panel of synthetic molecules also included the well-known NOD2 agonist muramyl-dipeptide MDP (MurNAc-l-Ala-d-IsoGln) and its inactive isomer MDP-ll which serve as positive and negative controls, respectively [42,43]. For human cell immunostimulation, we first used human macrophage-like THP-1 cells differentiated using phorbol 12-myristate 13-acetate (PMA). These cells produce elevated levels of the cytokine interleukin-8 (IL-8) when stimulated with MDP [44], which we confirmed (Fig 5A). As expected, the negative control MDP-ll, had no stimulatory effect. All muropeptides (i.e., no anhydro bond) stimulated IL-8 production (Fig 5A). The presence of GlcNAc to form the disaccharide-peptide species did not stimulate IL-8 production to the same extent (Fig 5A). Importantly, all the corresponding anhydromuropeptides displayed little to no stimulatory activity of IL-8 production relative to their corresponding muropeptides (p = 0.005, S11A Fig). Peptide-only species also had no detectable stimulatory activity (Fig 5A). In a repeated comparative analysis, we included GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala, the shed anhydromuropeptide with the two terminal d-Ala (PGBb fragment #3 in Fig 1 and S1 Table). This additional analysis confirmed that the presence of an anhydro bond considerably reduced the stimulation of IL-8 production irrespective of the presence or absence of the d-Ala- d-Ala moiety (S11B and S11C Fig).
A. Plot showing IL-8 production in differentiated THP-1 cells in the presence of different synthetic PG fragments. Bar height represents the mean. Dots represent data from three biological replicates. The legend in the top right defines the schematics for the synthetic PG fragments. A statistical comparison between the muropeptides and the anhydromuropeptides is presented in S11A Fig. B. Plot showing secreted embryonic alkaline phosphatase (SEAP) activity, a proxy for NF-κB activation, measured as absorbance at 655 nm (A655), in human NOD2 reporter cells (after correction using NOD2-null cells) following stimulation with the indicated molecules. Each dot represents a different biological replicate, and the bar height is the mean of the two replicates. A statistical comparison between the muropeptides and the anhydromuropeptides is presented in S12A Fig.
To examine these effects in the context of NOD2, we tested the ability of key synthetic PGBb fragments to stimulate NF-κB in the HEK-Blue human NOD2 (hNOD2) reporter cell line relative to the NOD2-null parental cell line from which it was derived. For this experiment, we used two concentrations (1 and 30 µM) of synthetic PGBb fragments. The positive control (MDP) displayed strong NF-κB activation at both concentrations (Fig 5B), with a saturating absorbance (A655) near 1.25 (S11D Fig). As expected, none of the peptides alone resulted in NF-κB activation whereas all tested muropeptides resulted in saturating NF-κB activation, even at the lowest concentration (Fig 5B). Conversely, exposure to the corresponding anhydromuropeptides resulted in little to no effect (Fig 5B). In all cases, the lowest concentration (1 µM) of a muropeptide generated a stronger response than the highest concentration (30 µM) of the corresponding anhydromuropeptide, indicating that the anhydro bond formation on the MurNAc residue created by MltS decreases NOD2-dependent stimulation by at least 30-fold (p = 0.04, S12A Fig). Our results imply that through anhydro bond formation, the LTGase activity of MltS helps live B. burgdorferi evade NOD2-dependent detection despite continuously shedding PGBb material during growth.
The low immunogenicity of the shed PGBb monomers questioned the origin of the NOD2-stimulating NF-κB activity that our laboratory previously found in the supernatant of B. burgdorferi cultures [8]. Therefore, we re-examined this activity on hNOD2 reporter cells and found no measurable stimulatory activity from culture supernatants of various B. burgdorferi strains compared to the positive control MDP (S12B Fig). The reason for the discrepancy is not clear. It is possible that the previously reported stimulatory activity originated from a gradual leakage of PGBb material from the sacculi of lysed or membrane-fragilized spirochetes into the culture over time. Leakage of PG material from dead cells may also explain residual NOD2-stimulatory activity previously reported for culture supernatants of E. coli and other bacterial species [45]. We expect that PG contamination from dead cells may be more variable for B. burgdorferi cultures given that their “health” can easily fluctuate with small variations in the individual components of the complex growth medium, which can differ between batches [46–48]. Furthermore, one of the essential components of the B. burgdorferi growth medium is serum, which contains innate immunity factors (e.g., complement system). If incompletely heat-inactivated, these factors may contribute to cell killing or membrane destabilization, which, in turn, could result in the release of immunogenic PGBb fragments into the culture. However, we cannot rule out the possibility that live B. burgdorferi cells do release immunostimulatory PGBb material below the detection level of our current MS and hNOD2 reporter assays. Regardless, such PGBb material would likely be a minor released product compared to the poorly immunogenic PGBb turnover products identified in this study. In contrast, the polymeric PGBb sacculus isolated from spirochetes after cell lysis is rich in the pro-inflammatory molecular motif MurNAc-l-Ala-d-Glu readily sensed by NOD2 relative to the corresponding anhydro-N-acetylmuramyl form [8]. We found that pro-inflammatory MurNAc-peptide motifs remain abundant in PGBb sacculi isolated from 10-day-old stationary phase cultures (S13 Fig) in which >90% of the cells are dead (i.e., have lost their ability to proliferate upon nutrient repletion) [49]. These results suggest that at least under these experimental conditions, the composition of the PGBb sacculus remains pro-inflammatory when B. burgdorferi dies.
The levels of host peptidoglycan-hydrolytic activities vary between sera and synovial fluids across Lyme arthritis patients
The immunological results suggest that the primary immunostimulatory forms of PGBb derive from the sacculi, presumably when it becomes exposed after cell lysis. Exposed PGBb sacculi may then be digested by human hydrolytic enzymes. For instance, lysozyme has muramidase activity that cleaves the β(1,4)-glycosidic bond between MurNAc and GlcNAc. But unlike MltS and other bacterial LTGases, lysozyme does not produce an anhydro bond on the MurNAc residues and instead releases muropeptides that are pro-inflammatory (as illustrated in Figs 5 and S11 and S12). Humans can also produce an N-acetylmuramyl-l-alanine amidase, known as PGLYRP2 [50], which can abrogate PGBb-derived inflammatory activity by cleaving between MurNAc and l-Ala to release non-immunogenic peptides. Interestingly, human PG degrading activities can vary considerably across tissues and body fluids [51].
We reasoned that the levels of host PG hydrolytic activity could alter a PGBb-induced immune response depending on the anatomic sites that B. burgdorferi colonizes in patients. To examine this idea in the context of Lyme arthritis, we analyzed the digestion products of whole PGBb sacculi incubated for 0 or 6 h in either joint (synovial) fluid samples (n = 6) or serum (n = 4) from Lyme arthritis patients (color-coded in Fig 6) using LC-MS. The patients had a range of inflammatory responses and post-treatment durations of arthritis (see Materials and Methods for details). As an additional control, we analyzed the same set of 0 h incubation samples but without PGBb sacculi added. LC-MS analysis of the 6 h incubation products revealed predicted mass features of PG fragments in the bodily fluids that were virtually absent in the 0 h incubation samples or in the samples lacking PGBb sacculi (Figs 6A and S14A). This indicated that both fluids contained PG-hydrolytic activities. The release of disaccharides alone or in complex with a peptide indicated the presence of lysozyme activity in both fluids. However, the pattern of released fragments was distinct between sera and joint fluids. Incubation in joint fluids produced largely saccharide-peptides and virtually no peptide- or saccharide-only fragments (Fig 6A). In contrast, incubation of B. burgdorferi PG sacculi in sera released not only various saccharide-peptide conjugates but also free saccharides and peptides (Fig 6A). The different enrichments of peptide-only masses in sera versus saccharide-peptide monomers in joint fluids are illustrated with a subset of PG fragments in Fig 6B (the complete set is shown in Fig 6A). The results indicate that while both types of fluid display muramidase activity (based on the presence of disaccharides alone or in complex with peptides), they considerably differ in their N-acetylmuramyl-l-alanine amidase activity. Serum samples had significant N-acetylmuramyl-l-alanine amidase activity that cleaved saccharide-peptides into individual saccharides and peptides, whereas joint fluid samples exhibited little, if any, such activity (Figs 6A and 6B and S14B). This was also true when comparing samples from the same (color-coded) patients. We also noted a wide variability in PG-hydrolytic activities across patients (Figs 6A and 6B and S14B). The tissue-specific trends in PG-hydrolytic activities did not appear to be unique to Lyme arthritis patients as they could also be observed in the joint fluids of rheumatoid arthritis patients (n = 3) and the pooled serum of healthy individuals (Figs 6 and S14B).
For all panels, the identities (IDs) of Lyme arthritis patients are color-coded. The same color indicates that the serum and joint fluid were obtained from the same individuals. A. Heatmap of predicted PGBb fragment species released from digestion of purified PGBb sacculi in six joint fluid samples and four serum samples from Lyme arthritis patients. For all samples, sacculi were incubated with either fluid for 0 h (left) or 6 h (right), then the resulting reaction products were analyzed by LC-MS. PGBb fragment species were detected by their predicted [M+H] value (S1 Table and S1 Dataset). The accompanying table on the left contains the key to interpret the predicted identity of PGBb fragment species in the heatmap. Also shown is a schematic illustrating the cut sites for the indicated enzymes. B. Representative quantifications of peptide or sugar-peptide conjugate digestion products in serum and joint fluid samples predicted based on their masses. Each dot was derived from integrating the relevant EIC peak. Mann-Whitney U test was used to determine the p values as the data spanned log distances. C. ELISA results for either lysozyme or PGLYRP2 for the same joint fluid and serum samples as in (A) and (B). Error bars represent mean ± standard deviation. p values were obtained using a Welch t-test since the groups had unequal variances and N values.
To examine whether the observed differences in enzymatic activities could at least in part be attributed to differences in levels of lysozyme and PGLYRP2, we measured the abundance of these proteins in the same samples using an enzyme-linked immunosorbent assay (ELISA). This assay showed that the levels of lysozyme and PGLYRP2 in sera or joint fluids were indeed variable across individuals (Fig 6C). Samples with higher muramidase or N-acetylmuramyl-l-alanine amidase activity based on the overall PGBb digest profile (Fig 6A) had a higher concentration in lysozyme or PGLYRP2, respectively (Fig 6C). However, while the trends were preserved, the comparison was not fully consistent, suggesting that other unidentified PG-hydrolytic enzymes may be present in the samples. Importantly, the ELISA confirmed that joint fluids were associated with a generally lower level of PGLYRP2 compared to sera (Fig 6). Collectively, these findings suggest a potential role for human N-acetylmuramyl-l-alanine amidase activity in general and PGLYRP2 in particular in tissue-specific immunopathogenesis induced by lingering PG (as discussed below).
Discussion
Our study identifies the predominant PG fragments present in the supernatant of B. burgdorferi cultures (Fig 1). Our immunological assays (Figs 5 and S11 and and S12) suggest that these PGBb turnover products have low pro-inflammatory activity because of two key chemical features: (1) their peptide stems include an Orn residue at the third amino acid position [8,10] in place of the more common DAP residue found in diderm bacteria [52], and (2) their MurNAc residues carry an anhydro bond linking C1 and C6. The presence of Orn instead of DAP precludes immune recognition by the PG-specific receptor NOD1 [53,54] whereas the anhydro bond prevents detection by NOD2. Results from a recent study suggest a molecular mechanism for the latter effect, showing that NOD2 is preferentially activated by MurNAc-dipeptides that are phosphorylated by the mammalian N-acetylglucosamine kinase NAGK [55]. Phosphorylation requires the availability of a hydroxyl group on the C6 position of MurNAc. The implication, which was not mentioned in the NAGK study [55], is that all anhydromuropeptides produced by bacterial LTGases (including MltS) cannot be phosphorylated by NAGK, as the process of anhydro bond formation eliminates the free hydroxyl group on C6 [31]. Thus, in addition to limiting the length of glycan strands in the PG sacculus [28,29,32–34], LTGase activity also provides an effective means for bacteria to remodel their sacculi during growth without generating PG turnover products detectable by the NOD2 pathway. This conclusion is consistent with previous reports of the immunomodulatory effects of Helicobacter pylori and Neisseria gonorrhoeae LTGases [38,39]. Given the wide distribution of genes encoding LTGases across diverse bacterial phyla [31], the 1,6-anhydro linkages that these enzymes create in PG turnover products may represent an ancient strategy for evasion of NOD2-dependent immune response. This could particularly be a beneficial strategy for Gram-positive bacteria that most often produce Lys-type PG [52], which, like Orn-type PG, do not trigger a NOD1-dependent immune response [53,54].
Whether the shed PGBb turnover products identified herein mediate beneficial interactions between B. burgdorferi and its various hosts in nature remains to be determined. Interestingly, anhydromuropeptides have been shown to act as chemical messengers between certain bacteria and their hosts, triggering cell signaling events unrelated to innate immune clearance [56–58]. For example, anhydromuropeptide release has been shown to play a critical role in enabling the bacterium Vibrio fischeri to establish its symbiosis with the squid Euprymna scolopes. During growth, V. fischeri releases 1,6-anhydro-disaccharide-tetrapeptides that help trigger key morphogenic events in the squid’s nascent light organ, ultimately facilitating its colonization by V. fischeri [59]. By analogy, it is possible that 1,6-anhydro-disaccharide-peptides shed by B. burgdorferi during its growth in the midgut of a feeding tick may alter the tick vector’s physiology to facilitate B. burgdorferi colonization or subsequent transmission. Further experimentation will be required to test this hypothesis. Using the bb0259 knockout (ΔmltS) strain, which sheds little to no anhydromuropeptides (Fig 4), may seem attractive for such studies. However, the ΔmltS strain is already expected to be non-infectious due to its cell motility defect [36]. It has been well-established that motility is critical for B. burgdorferi’s life cycle [60–62]. It is also possible that the release of PGBb fragments during B. burgdorferi growth does not confer any fitness advantage and is merely a consequence of the loss of PG recycling genes during the evolution of this spirochete as an obligate parasite, which has led to a reduction in genome size. E. coli mutants deficient for PG recycling have no reported fitness cost in laboratory cultures [56]. Furthermore, while B. burgodorferi lacks the AmpG transporter (which is specific to PG fragments containing an anhydro-N-acetylmuramyl residue [63]), it carries other transporters that allows this pathogen to uptake precursors of PG synthesis (such as GlcNAc and amino acids) from its host environment [64–66]. This scavenging capability may obviate the need for a functional PG recycling pathway.
Importantly, our findings suggest that the pathogenic form of peptidoglycan in Lyme arthritis patients is polymeric PGBb material from dead spirochetes. In a study investigating B. burgdorferi burden and viability, all spirochetes identified in Lyme arthritis joint fluid samples were found to be moribund or dead, and spiking joint fluid samples (diluted 1:10 or 1:100) with 102, 104, or 106 cultured B. burgdorferi cells was found to result in rapid spirochete killing [67]. Thus, the joint fluid, which contains high-titer B. burgdorferi antibodies, proinflammatory cytokines/chemokines, and complement components [68,69], constitutes a generally lethal environment for spirochetes, thereby restricting infection to protected niches within the affected joint tissues [67]. We hypothesize that immunogenic MurNAc-peptides from the PGBb sacculus become exposed to the immune system as B. burgdorferi cells lyse from the effects of initial immune responses or antibiotic treatment. Systemic injection of streptococcal PG in rats have shown that cell wall material can persist for weeks to months in the animals and that the localized presence of PG in joint tissues is associated with acute and chronic inflammation [70,71]. A study published during the revision of our manuscript demonstrates that polymeric PGBb persists in the joints of Lyme arthritis patients [72], consistent with PGBb from dead spirochetes being the pathogenic form.
In tissue culture of synovium from a patient with postinfectious Lyme arthritis, HLA-DR-expressing fibroblast-like synoviocytes, the most common cells in the synovial lesion, were found to be IFNγ-inducible antigen-presenting cells that present autoantigens [14]. Moreover, when cultures were primed with IFNγ and PGBb, they secreted much higher levels of IFNγ, suggesting that the combination of IFNγ and PGBb may lead to enhanced activation of proinflammatory autoreactive T cells [14]. Several host factors may bolster responsiveness to PG-derived immunogens. For instance, increased NOD2 expression has been identified in synovial tissues isolated from patients with postinfectious Lyme arthritis [11]. In addition, the level of N-acetylmuramyl-l-alanine amidase activity and the abundance of PGLYRP2, which is expected to limit NOD2 activation, are low in synovial fluids—and thus presumably within the synovium—relative to serum (Figs 6 and S14). Low PGLYRP2 activity, combined with elevated NOD2 level, may predispose joint tissues to PGBb-mediated inflammation. Furthermore, we observed a large variability in PGLYRP2 and other PG-hydrolytic activities across samples (Fig 6). Whether this variability contributes to differences in disease progression among individuals is an intriguing possibility that will require longitudinal studies to be examined. It is also worth noting that PGLYRP2 activity has been reported to be particularly low in cerebrospinal fluid [51], raising the possibility that PGBb may play a role in neuroborreliosis. Altogether, our study suggests a potential link between chronic inflammation and innate immunity.
Supplementing the inflamed tissues of Lyme arthritis patients with PGLYRP2 activity may, in theory, help mitigate PG-mediated immunopathology. Given the higher PGLYRP2 activity in the serum of Lyme arthritis patients (Fig 6), intraarticular injections of blood-derived products from autologous origin (i.e., obtained from the same individual) may be an effective treatment strategy for PG-induced pathology. For example, platelet-rich plasma injections are often used as orthobiologics to help heal damaged tissues [73,74]. Further studies on PGLYRP2 are recommended before exploring this treatment option for antibiotic-refractory Lyme arthritis and other potential PG-induced inflammatory pathologies [75–77], as PGLYRP2 may have pro-inflammatory activity downstream NOD2 [78].
Materials and methods
Bacterial strains and growth conditions
Strains used in this study are detailed in S2 Table. B. burgdorferi cells were cultured in complete Barbour-Stoenner-Kelly (BSK)-II medium in humidified incubators at 34ºC under 5% CO2 atmosphere [64,79,80]. Complete BSK-II contained 50 g/L bovine serum albumin (BSA, Millipore # 81–003), 9.7 g/L CMRL-1066 (US Biological # C5900-01), 5 g/L neopeptone (Thermo Fisher # 211681), 6 g/L HEPES acid (Millipore # 391338), 5 g/L D-glucose (Sigma # G7021), 2 g/L yeastolate (Difco # 255772), 0.7 g/L sodium citrate (Sigma # C7254), 0.8 g/L sodium pyruvate (Sigma # P5280), 2.2 g/L sodium bicarbonate (Sigma # S5761) and 0.4 g/L N-acetyl-glucosamine (Sigma # A3286). The pH of the medium was adjusted to 7.6, then supplemented with 60 mL/L heat-inactivated rabbit serum. Heat inactivation involved incubating the serum at 50ºC in a water bath for 30 min prior to use in medium preparation. Unless explicitly noted, all B. burgdorferi cultures were maintained in exponential phase at a density below 5 x 107 cells/mL. Cell density was determined through direct cell counting using disposable Petroff-Hausser chambers and darkfield microscopy as previously described [81]. When appropriate, relevant B. burgdorferi strains were cultured in the presence of antibiotics at the following final concentrations: 200 µg/mL for kanamycin [82] (Sigma # K1377), 40 µg/mL for gentamicin [83] (Sigma # G1914), and 100 µg/mL for streptomycin [84] (Sigma # S6501).
Verification of plasmid content in B. burgdorferi strains
Three biological replicates of B. burgdorferi strains B31 IR, K2, 297, and N40 were grown to a density between 1 and 4 x 107 cells/mL in 14 mL complete BSK-II medium. The resulting cultures were centrifuged at 9000 x g for 5 min at 25ºC. Cell pellets were processed using a QIAGEN DNeasy Blood & Tissue Kit (# 69504) to isolate genomic DNA (gDNA). Purified gDNA was sent for Illumina whole-genome sequencing using SeqCenter in Pittsburgh, PA, USA with a minimum read count of 1.33 million reads per sample. Different reference genomes were used for analysis: ASM4079079v1 for strain 297 [85,86], ASM868v2 for strains B31 IR and K2 [16,85], and ASM16663v1 for strain N40 [85,86]. Since the reference genome ASM4079079v1 for strain 297 is missing five cp32 plasmids, additional sequences were obtained from a previous study [20] and appended to the reference: cp32–1 (Accession # CP002254), cp32–5 (Accession # CP002261), cp32–6 (Accession # CP002263), cp32–9 (Accession # CP002262), and cp32–12 (Accession # CP002255). Reads were aligned to their respective reference using Breseq [87]. The resulting alignment “.bam” files were then used to calculate coverage using the Python package HTSeq [88]. The coverage array was loaded using the function GenomicArray and then quantified using the function GenomicInterval for the number of reads in a 4000-bp search window across each genetic element. The counts in each search window were normalized to the total number of alignments for the genetic element in question. The fold change of each genetic element was calculated by taking the mean counts for each element and dividing it by the mean counts for the chromosome. Due to the repetitive nature of some B. burgdorferi plasmid sequences, plasmid elements with a fold change under the arbitrary value of 0.25 were counted as missing that plasmid.
Verification of the Himar1 transposon insertion site in the bb0605::Himar1 strain T08TC493
B. burgdorferi strains 5A18NP1 (B31-A) and T08TC493 (5A18NP1 bb0605::Himar1) were grown to 5 x 107 cells/mL in 14 mL complete BSK-II. They were then centrifuged at 9000 x g for 5 min at 25ºC. Cell pellets were then processed using a QIAGEN DNeasy Blood & Tissue Kit (# 69504) to isolate genomic DNA (gDNA). The bb0605 locus was then amplified by PCR using primers 5’- AAATGGCTCCTTTTTAATTGTATTGTAAT -3’ and 5’- TTCACCAGGAACTATTATTGTAACAT -3’. After confirming amplification by agarose gel electrophoresis, the remaining volume of PCR products was processed using a QIAquick PCR Purification Kit (QIAGEN # 28104) and then the PCR products were sequenced to determine the insertion site of the Himar1 transposon, which was found to have disrupted the bb0605 open reading frame 300 bp downstream of the first codon.
Purification of whole B. burgdorferi PG sacculi
Sacculi were purified in a manner similar to that described previously [89]. Briefly, two flasks of 1 L BSK-II medium were inoculated with B. burgdorferi to a starting density of 1 x 104 cells/mL. Once the cultures reached 1 x 108 cells/mL (Figs 3 and 6 and S7, and S14), or after 10 days in stationary phase (S13 Fig), cells were centrifuged at 6000 x g for 20 min at 4ºC in successive 333 mL batches into the same two 500 ml polypropylene centrifuge tubes (Corning # 431123). Between each centrifugation, pellets were dislodged by vigorously swirling with the added culture. After the entire culture volume was centrifuged, the pellets were washed three times with cold phosphate-buffered saline (PBS, VWR # 76371–734), shaking vigorously to achieve a homogenous distribution of cells. The final pellets were stored at -80ºC overnight.
The following day, the pellets were resuspended in 6 mL chilled PBS and placed on ice. Separately, 6 mL of 10% w/v sodium dodecyl sulfate (SDS) per 1 L of cells to be processed was brought to a boil. The cell suspension in PBS was then added dropwise to the boiling SDS and allowed to continue boiling for an additional 30 min before being allowed to cool to room temperature. The lysed cell suspension was then transferred to glass culture tubes that were placed in a beaker filled appropriately with Milli-Q H2O. The glass culture tubes were mixed with a stir bar as the water was boiled for 2.5 h on a hotplate. The hotplate was subsequently turned off while the samples continued to be stirred overnight as they re-equilibrated to room temperature.
On the third day, the content of each tube was transferred to ultracentrifuge tubes and pelleted at 150,000 x g for 20 min at 20ºC. The pellets were washed four times with 10.5 mL Milli-Q H2O, centrifuging each time at 150,000 x g for 20 min at 20ºC. After washing, the pellets were resuspended in 1 mL 100 mM Tris-HCl buffer (pH 7.5). Ten microliters of a 20 µg/mL solution of alpha-amylase (Sigma # 10102814001) were added to each suspension and incubated at 37ºC for 2 h, shaking at 220 rpm. Next, 1 mL Tris-HCl buffer (pH 7.5), 40 µL 1 M MgSO4, and 2 µ L nuclease mix [i.e., 100 µg/mL DNase I (Roche # 11284932001) + 500 µg/mL RNase A (Roche # 10109142001) dissolved in Milli-Q water] were added to each sample, followed by a 2 h incubation at 37ºC while shaking at 220 rpm. Lastly, 50 µL of 50 mM CaCl2 and 100 µL of a 2 mg/mL solution of chymotrypsin (Sigma # C4129) were added to each sample. The final suspensions were allowed to shake overnight at 220 rpm and 37ºC.
On the final day, the chymotrypsin was inactivated by adding 200 µL of 10% SDS and boiling the samples in a water bath for 10 min. The contents of all tubes representing a common sample were combined into a single ultracentrifuge tube and washed six times with 10.5 mL Milli-Q H2O. For each wash, the samples were centrifuged at 150,000 x g for 20 min at 20ºC in an ultracentrifuge. After the final wash, the pellet was resuspended in 1 mL sterile Milli-Q H2O. Two hundred microliters of the final suspension were transferred to a pre-weighed Eppendorf tube for lyophilization. The dry mass of the lyophilized product was measured to estimate the PG concentration of the starting suspension.
Extraction of PGBb fragments from culture supernatants
B. burgdorferi cultures at the relevant densities (between 104 and 108 cells/mL) were used (see Figs 1, 2, 4, and S1–S5, S7, and S9 for respective harvest times/cell densities). PG material was extracted using an acetonitrile:methanol extraction method. Briefly, 1 mL of relevant cultures was centrifuged and the supernatant filter-sterilized through a 0.1 µm PVDF syringe filter (Celltreat # 229740) into a separate tube, which was then stored at -20ºC until use. One hundred-fifty microliters of culture supernatant was mixed with 450 µL of a 1:1 mixture of acetonitrile:methanol (prepared fresh, chilled to -20ºC before use), vortexed, and sonicated at room temperature for 10 min in a water bath sonicator. The sample was then placed at -20ºC for 1 h and vortexed every 30 min. Insoluble debris were pelleted at 15,000 x g for 20 min at 4ºC, then ~85% of the supernatant volume was carefully transferred to a new tube. The solution was dried in a Labconco centrivap (#7810014) at 37ºC for ~6 h after which the pellets were stored at -20ºC until use. Samples were resuspended with 150 µL LC-MS grade water (MilliQ H2O) for mass spectrometry.
Digestion of B. burgdorferi sacculi for liquid chromatography coupled to mass spectrometry
To determine the composition of PGBb sacculi isolated from either the bb0605::Himar1 (T08TC493) strain or its parent (5A18NP1) (Fig 3), muramidase reactions were prepared consisting of 2 µL of mutanolysin (1 mg/mL), 2 µL of Tris-HCl (pH 7), ~ 125 µg of PG, and Milli-Q H2O to bring the final volume to 100 µL. These samples were vortexed, spun down, and then incubated overnight at 37ºC, shaking at 700 rpm. The following day, digests were boiled at 100ºC for 5 min to denature the mutanolysin. The samples were then centrifuged at 20,000 x g for 15 min at room temperature. The supernatant was diluted 1:10 in Milli-Q H2O, with 150 µL being set aside for LC-MS. The same procedure was performed to analyze the composition of mutanolysin-digested PGBb sacculi isolated from 10-day-old stationary phase cultures of the B31 IR strain (S13 Fig).
To assess the ability of joint fluids or sera from Lyme arthritis patients to digest PG, 5 µL whole sacculi (1.73 mg/mL) from strain T08TC493 was mixed with 90 µL of each body fluid and 5 µL Milli-Q H2O. A negative control consisting only of 45 µL of each patient fluid and 5 µL Milli-Q H2O was included. Half of the samples to which PG was added were immediately set aside to serve as a 0 h time point, while the rest of the samples was incubated at 37ºC for 6 h, shaking at 750 rpm. These samples were then stored at -20ºC until they were ready for processing. Once ready, 40 µL thawed samples were mixed with 160 µL 1:1 mixture of acetonitrile:methanol. Following this, samples were processed further for LC-MS as described above.
To test whether components of the BSK-II medium degrade PG, 5 µL whole sacculi (1.25 mg/mL) purified from strain B31 IR was mixed with 5 µL Milli-Q H2O and 90 µL BSK-II medium (containing 6% of heat-inactivated rabbit serum) or 100% heat-inactivated serum. Replicates of rabbit serum were derived from separate lot numbers to check batch-to-batch variability. The “no PGBb” controls contained 45 µL of BSK II or heat-inactivated rabbit serum and 5 µL Milli-Q H2O. Samples were incubated at 37ºC for 24 h, shaking at 750 rpm. Samples were then further processed for LC-MS as described above.
Liquid chromatography coupled to mass spectrometry
LC-MS experiments were performed using an Agilent QTOF 6545, coupled with an Agilent 1290 Infinity II ultra-high-pressure liquid chromatography (UHPLC) device. Samples were separated on a Kinetex Polar C18 column with a 100 Å pore size, 2.6 µm particle size and 2.1 x 100 mm in size (Phenomenex #00A-4759-AN), with the guard column Securityguard Ultra Holder (Phenomenex #AJ0–9000). Buffers used were A: LCMS-grade H2O + 0.1% formic acid (Sigma # 1590132500) and B: acetonitrile + 0.1% formic acid (Sigma # 900686) on a gradient from 0–95% B. The gradient for the LC experiments is described in S3 Table. The column temperature was maintained at 40ºC during the experiment. Ten microliters of sample were injected per run.
Quadrupole time-of-flight (QTOF) MS settings were as follows. All PGBb molecules were detected in the positive ionization mode with the instrument mass range set to 70–1700 Da. The scan rate was 1.5 spectra/s. Fragmentor voltage was set to 175 V. For MS/MS fragmentation (S1-S5 Figs), the QTOF collision energy for the targeted released muropeptide masses was set as indicated in S1–S5 Figs.
For analysis, Agilent “.d” files were converted into “.mzML” files using MSConvert [90]. The python package pymzmL was used to analyze the mzML files [91]. Extracted ion chromatograms were constructed using pymzmL’s run function and by searching each scan in the retention time for the candidate molecule ± 20 parts per million (ppm), while the total ion chromatograms summed total counts across every run time. Integrated signal for a single species was performed by summing the relevant area under the ion peaks.
The initial screen (Fig 1C) was analyzed using the XCMS package in R [92–94]. Briefly, chromatogram peaks were detected using the function findChromPeaks with parameters defined by the function CentWaveParam. Peak criteria were defined as ,
,
,
, and
. Neighboring peaks were merged using the function RefineChromPeaks, specifying refining parameters with MergeNeighboringPeaksParam. Merging criteria were
,
, and
. Statistical significance was determined by XCMS’s pval function, which uses a Welch’s two-sample t-test. All significant hits (p < 0.05, fold change > 3) were then checked against the theoretical PGBb masses in python using the packages numpy and pandas [95,96]. Identified targets were validated based on enrichment of EIC peaks in culture supernatants over BSK-II alone, valid isotopic distributions, and MS/MS fragmentation.
To screen for putative PG species (Figs 6A and S14A), masses of theoretical PGBb fragment species were concatenated into a single vector containing all [M+H]+ and [M+H]2 + values. Extracted ion count (EIC) profiles were constructed for every value between retention times of 1 and 15 min of a 20-min run to exclude nonspecific compounds that wash off the column. Scipy’s find_peaks function was then used to identify peaks as ,
in retention time seconds,
to capture width from the base of the peaks of interest, and
for a minimum signal-to-noise threshold. Identified hits were then verified to have an isotopic abundance distribution of two decaying peaks, the first of which being at least 1000 counts high. The most abundant peak was selected and summed for quantification. Identified masses from this process were then checked against the theoretical PGBb library. Identified hits were verified by constructing EICs profiles and checking that the elution profiles were consistent with previous observations. Inconsistent observations were removed from consideration.
Heat maps in Figs 6A and S14A were compiled from the extracted ion counts, keeping only features that showed at least three-fold enrichment over the negative controls (0 h or no-PGBb conditions). The maximum value of extracted ions for features corresponding to identified PGBb species in any sample had to be at least 10,000 to be considered.
Microscopy
The cell densities of B. burgdorferi cultures were determined by dilution in PBS and using an In-Cyto C-Chip disposable hematocytometer (InCyto # DHC-N01) and darkfield illumination in a Nikon Eclipse E600 microscope with a 40x 0.55 NA Ph2 phase contrast air objective and darkfield condenser lens. For fluorescence microscopy, samples were spotted on 2% PBS agarose pads [27,97]; covered with a No. 1.5 coverslip; and sealed with VALAP, a 1:1:1 mixture of Vaseline petroleum jelly (Amazon ASIN B07MD6HJT4), lanolin (Spectrum # LA109) and paraffin wax (Fisher # 18-607-738), on all edges. Specimens were imaged using Nikon Eclipse Ti inverted microscopes with a 100x Plan Apo 1.45 NA phase contrast oil objective, Hamamatsu Orca-Flash4.0 V2 CMOS camera, a Sola LE light source (phase contrast), and a Spectra X Light engine. For the acquisition of fluorescent HADA images a DAPI filter set was used (Chroma 49028: ET395/25 ex, dichroic T425lpxr, ET460/50 em). The microscope was controlled by NIS-Elements AR.
HADA labeling of B. burgdorferi cells
Strains 5A18NP and T08TC493 were grown to high 106 or low 107 cells/mL densities. The morning of the experiment, 1 mL of each culture was set aside. Two microliters of 50 mM HADA (Tocris # 6647) were pipetted into each tube, which was then covered in aluminum foil and mixed by inversion. The samples were incubated at 34ºC. After 1 h and 8 h of incubation, 200 µL was removed from the samples and placed in a 1.5 mL Eppendorf tube. These 200 µL aliquots were immediately centrifuged at 9,000 x g for 5 min at room temperature, washing two times in 500 µL BSK-II without phenol red. The final pellet was resuspended in 20–100 µL of phenol red-free BSK-II depending on the pellet size. Five microliters were spotted on a 2% PBS agarose pad for immediate imaging. Phase contrast images were acquired with a 500 ms exposure while HADA fluorescence was imaged with the DAPI filter set using 385 nm excitation at 40% power with an exposure of 1000 or 250 ms based on the 1 or 8 h of incubation time with HADA, respectively. For analysis, the intensity of cells was multiplied to equalize all time points to 1000 ms for comparison.
Image analysis
FIJI [98] was used for the preliminary assessment of fluorescence images, then Python was used for the remaining work. First, to facilitate analysis, we loaded large Nikon ND2 files as arrays using the previously published function nd2_to_array function [99]. To create reliable masks of phase contrast images, an adaptive threshold from the Python package OpenCV (cv2.adaptiveThreshold) was applied, excluding objects smaller than 500 square pixels. Any surviving masks were kept and skeletonized. Cell skeletons were used to measure the width along the mask. Cells at least 4 µm long and cell masks less than 0.7 µm wide were selected. The surviving masks were assigned an ID and archived in a Pandas data frame for cell length and fluorescence measurements.
Linescans were generated by first measuring the medial axis down the center of the mask using the function get_medial_axis generated as before [100]. The medial axis is a sub-pixel polynomial fitting from pole-to-pole. The medial axis was then used to measure cell lengths and retrieve the corresponding pixel intensities in the fluorescence image. The medial axis, cell length, and linescan measurements were also saved in the same Pandas data frame corresponding to each cell ID. Demographs were created by constructing a Python dictionary of all cell linescans in a dataset. They were ordered from shortest to longest, then arranged into a numpy array centered at mid-cell. Each line scan was normalized by z-score to show where signal was enriched.
To measure fluorescence in each cell, background-subtracted images were produced in Python using a modified background subtraction algorithm [99]. Phase contrast images were segmented first using OpenCV’s adaptive threshold (cv2.adaptiveThreshold) to remove all potential fluorescing objects. These masks were dilated using Scipy’s binary_dilation function with ten iterations [101]. The dilated objects were then removed from the fluorescent image. Surviving pixels were binned and averaged using a rolling window across the x and y dimensions, then smoothed with a Gaussian kernel to obtain an estimated “background-only” image. Cell masks were used to measure the mean intensity (integrated intensity per unit pixel area) from every cell in the background-subtracted images.
Human subject samples
The study patients with Lyme arthritis met the criteria of the Centers for Disease Control and Prevention for B. burgdorferi infections [102]. They had knee swelling and pain and positive antibody responses to B. burgdorferi, as determined by ELISA and Western blot. The patients were treated according to the guidelines of the Infectious Diseases Society of America [103]. They had persistent arthritis despite one to two months of oral antibiotic therapy (usually doxycycline), followed by an additional one month of intravenous (IV) antibiotic therapy (ceftriaxone).
The six Lyme disease patients had a range of inflammatory responses and post-treatment durations of arthritis that were typical of more severe Lyme arthritis. Three patients had the resolution of arthritis one to three months after IV antibiotic therapy, whereas the other three had postinfectious arthritis lasting four to nine months after IV therapy. In three of the six patients, synovial fluid samples were obtained prior to starting IV antibiotic therapy when joints are typically swollen. In the remaining three patients, synovial fluid samples were obtained prior to starting synovectomy (n = 1) or therapy with disease-modifying antirheumatic drugs or DMARDs (n = 2). When samples were obtained, the median white cell count in synovial fluids was 17,022 cells/mm3 (range 1,567–31,286); whereas in blood, the median C-reactive protein (CRP) value was 28.4 (range 8–71.4), and the median erythrocyte sedimentation rate (ESR) was 28.5 (range 7–49). In four of the six patients, corresponding serum samples were available.
The three patients with rheumatoid arthritis had symmetrical polyarthritis affecting large and small joints. Samples were obtained during flares of arthritis one, four, and six years after disease onset. Patients were taking disease modifying anti-rheumatic drugs (DMARDs) at that time. Synovial fluid white cell counts ranged from 7,776–20,300 cells/mm3, ESR values were high (62–66), and CRP values were also elevated (18.5 to 27.8). One patient had positive test results for both anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF), one had a positive test for ACPA alone, and one had negative results for both tests.
To exclude sampling artifacts as an additional source of variation, serum and joint fluid samples were processed within hours after aspiration of synovial fluid. The samples were centrifuged at 300 x g for 10 min, followed by another centrifugation at 3000 x g for 10 min to remove cells and cell debris as previously described [104]. Samples were stored in 1.5 mL aliquots in small plastic screw-top tubes and frozen at -80ºC without dilution or preservatives on the same day synovial fluid was obtained. Before each use, samples were centrifuged at 2,000 x g for 1 min to pellet potential remaining debris. No sample had undergone more than two freeze-thaw cycles before use in this study.
Enzyme-linked immunosorbent assays
Enzyme-linked immunosorbent assays (ELISA) were carried out using the PGLYRP2 ELISA Kit (MyBioSource # MBS2024542) and the Human Lysozyme ELISA Kit (Abcam # ab267798) using the manufacturer’s protocol. The patient samples for PGLYRP2 detection were diluted 200-fold in PBS to fall within the dynamic range of the kit standards, while the samples for lysozyme detection were diluted 12,000-fold in PBS.
THP-1 and NOD2 reporter cell stimulation
The panel of synthetic PGBb molecules used for the immunological assays were synthesized as previously described [41]. Two assays were performed to examine the immunostimulatory activities of these molecules. In the first one, THP-1 cells (ATCC # TIB-202) were grown in a humidified incubator at 37ºC under a 5% CO2 atmosphere in complete RPMI (cRPMI) containing 10% fetal bovine serum (FBS) + 1% Pen-Strep (Gibco RPMI 1640 # 11875119; R&D systems FBS – premium select, heat inactivated # S11550H; Gibco Pen-Strep # 15140122), with cell densities maintained between 1 x 105 and 1.5 x 106 cells/mL. For PGBb stimulation experiments, THP-1 cells were differentiated into macrophage-like cells in the presence of phorbol 12-myristate 13-acetate (PMA, InvivoGen # tlrl-pma). More specifically, cells were diluted to 1.25 x 106 cells/mL in cRPMI supplemented with 40 nM PMA, and 200 µL of the resulting cell suspension were added to the appropriate wells of a tissue culture-treated, flat-bottom 96-well plate (Fisher Scientific # FB012931) for a total of 2.5 x 105 cells/well. After 48 h, the PMA-containing medium was removed by aspiration, 200 µL of fresh cRPMI lacking PMA was added to each well, and the cells were allowed to rest for 72 h. Following this rest period, the medium in each well was exchanged for serum-free RPMI and the cells were starved in this manner for 4 h prior to PGBb stimulation. At the end of this interval, the serum-free medium was removed from each well using an aspirating pipette and then replaced with cRPMI containing a synthetic PGBb fragment at a final concentration of 30 µM. To account for differences in stock concentrations, each of the different potential ligands tested was first diluted in ultrapure water (American Bio # AB02123) to a concentration of 1 mM prior to further dilution to 30 µM in cRPMI. After a 24-h stimulation period, the supernatant was harvested from each well and immediately frozen at -80ºC. The supernatants were subsequently used for cytokine profiling by Luminex assay performed at Eve Technologies.
For the NOD2 reporter assay, HEK-Blue NOD2-overexpressing (hNOD2) and NOD2-deficient (Null2) cells (InvivoGen # hkb-hnod2v2 and hkb-null2, respectively) were maintained according to the manufacturer’s recommendations. In brief, both cell lines were grown in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich # D5796) containing 4.5 g/L glucose and 2 mM L-glutamine, and further supplemented with 10% FBS, 1% Pen-Strep, and 100 µg/mL Normocin (InvivoGen # ant-nr). Selective antibiotics were used in culturing both cell lines, beginning with the third passage after revival from frozen stock. Blasticidin (30 µg/mL, InvivoGen # ant-bl) and Zeocin (100 µg/mL, InvivoGen # ant-zn) were added to hNOD2 cell cultures, while only Zeocin was used for Null2 cell cultures. For PGBb stimulation and measurement of the resulting NOD2-dependent NF-κB activation by secreted embryonic alkaline phosphatase (SEAP) assay, 20 µL of each synthetic PG molecule was prepared by dilution in ultrapure water to a stock concentration of 300 µM and added to the appropriate wells of a tissue culture-treated, flat-bottom 96-well plate to the indicated final concentrations. The hNOD2 and Null2 cells were detached from the T75 flasks in which they had been expanded by exchanging the growth medium in each for 5 mL pre-warmed PBS and gently tapping the flask sides. Cells were fully resuspended by gentle pipetting and then counted using a disposable hemocytometer. Pre-warmed HEK-Blue Detection medium (InvivoGen # hb-det2; reconstituted according to manufacturer’s recommendations) was then added to each cell suspension to achieve a final cell density of 2.8 x 105 cells/mL. Next, 180 µL of the resulting cell suspension (or a total of approximately 5 x 104 cells) were added to the appropriate wells of the 96-well plate described above such that the final PG fragment concentration in each well was either 1 or 30 µM. The plate was then placed at 37ºC in a humidified incubator containing 5% CO2 and SEAP production was assessed by absorbance measurement at 655 nm (Molecular devices, SpectraMax i3X) after 16 and 22 h of incubation.
For S11D Fig, about 50,000 HEK-Blue hNOD2 reporter cells (eighth passage) in a volume of 180 µL HEK-Blue Detection medium were added to each well containing 20 µL synthetic MDP (Invivogen # tlrl-mdp) diluted in ultrapure water such that the final MDP concentration ranged from 5 nM to 100 µM across a row of a 96-well plate. Plates were incubated for 16 h in a humidified incubator at 37ºC and 5% CO2, with subsequent absorbance measurements being obtained at 655 nm.
To prepare B. burgdorferi culture supernatants for HEK-Blue hNOD2 reporter stimulation (S12B Fig), B. burgdorferi starter cultures were used to inoculate 10 mL complete BSK-II medium (supplemented with 200 µg/mL kanamycin) to obtain a starting cell density of ~104 cells/mL. As a medium-only control, 10 mL complete BSK-II medium (also supplemented with kanamycin) was subjected to the same conditions (humidified 34ºC and 5% CO2 environment with tube cap loosened) as B. burgdorferi cultures. Once the cultures reached a spirochete density of ~107 cells/mL, cells were pelleted, and supernatants transferred to fresh tubes that were immediately stored at -80ºC. Prior to application to HEK-Blue hNOD2-expressing reporter cells (fifth passage), thawed supernatants were passed through a 0.1 µm PES membrane filter (Foxx Life Sciences # 146–4113-RLS). HEK-Blue reporter cells were stimulated as before by exposure to 20 µL B. burgdorferi culture supernatant, complete BSK-II medium alone, MDP dissolved in ultrapure water (1 µM final concentration), or ultrapure water alone.
Computational analyses
For all custom-made analyses, R and Python scripts are available on the Jacobs-Wagner lab Github (https://github.com/JacobsWagnerLab/published/tree/master/McCausland_et_al_2025). Python packages numpy, scipy, scikit-image, seaborn, and pandas used in this study have previously been described [95,96,101,105,106]. The R package XCMS was previously described [92].
Raw MS data are available in the GlycoPOST repository [107] under accession numbers GPST000537 and GPST000595. Raw microscopy images are available in the BioImage Archive [108] under the accession number S-BIAD1573.
Supporting information
S1 Fig. Fragmentation of PGBb fragment l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala. A.
Schematic outlining each amino acid in l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala, along with notations of the origin of each identified fragment after MS/MS. B. EIC profile of the identified [M+H]+ profile. The peak of interest is shaded in red. C. The MS2 spectrum at the run time where the EIC peak in (B) is at maximum intensity. The collision energy used to fragment this molecule is indicated, and each identified fragment is marked with a letter corresponding to the schematic in (A).
https://doi.org/10.1371/journal.ppat.1013324.s001
(PDF)
S2 Fig. Fragmentation of PGBb fragment l-Ala-d-Glu-l-Orn-d-Ala-d-Ala. A.
Schematic outlining each amino acid in l-Ala-d-Glu-l-Orn-d-Ala-d-Ala, along with notations of the origin of each identified fragment after MS/MS. B. EIC profile of the identified [M+H]+ profile. The peak of interest is shaded in red. C. The MS2 spectrum at the run time where the EIC peak in (B) is at maximum intensity. The collision energy used to fragment this molecule is indicated, and each identified fragment is marked with a letter corresponding to the schematic in (A).
https://doi.org/10.1371/journal.ppat.1013324.s002
(PDF)
S3 Fig. Fragmentation of PGBb fragment GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala. A.
Schematic outlining the sugars and amino acids in GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala, along with notations of the origin of each identified fragment after MS/MS. B. EIC profile of the identified [M+H]+ profile of peak 1, shaded in red. C. The MS2 spectrum at the run time where EIC peak 1 in (B) is at maximum intensity. D. EIC profile of the identified [M+H]+ profile of peak 2, shaded in red. E. The MS2 spectrum at the run time where EIC peak 2 in (D) is at maximum intensity. F. EIC profile of the identified [M+H]+ profile of peak 3, shaded in red. G. The MS2 spectrum at the run time where EIC peak 3 in (F) is at maximum intensity. For (C), (E), and (G), the collision energies used to fragment this molecule are noted in the titles, and each identified fragment is marked with a letter corresponding to the schematic in (A).
https://doi.org/10.1371/journal.ppat.1013324.s003
(PDF)
S4 Fig. Fragmentation of PGBb fragment GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly).
A. Schematic outlining the sugars and amino acids in GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly), along with notations of the origin of each identified fragment after MS/MS. B. EIC profile of the identified [M+H]+ profile. The peak of interest is shaded in red. C. The MS2 spectrum at the run time where the EIC peak in (B) is at maximum intensity. The collision energy used to fragment this molecule is indicated, and each identified fragment is marked with a letter corresponding to the schematic in (A).
https://doi.org/10.1371/journal.ppat.1013324.s004
(PDF)
S5 Fig. Fragmentation of PGBb fragment GlcNAc-AnhMurNAc. A.
Schematic outlining each sugar in GlcNAc-AnhMurNAc, along with notations of the origin of each identified fragment after MS/MS. B. EIC profile of the identified [M+H]+ profile. The peak of interest is shaded in red. C. The MS2 spectrum at the run time where the EIC peak in (B) is at maximum intensity. The collision energy used to fragment this molecule is indicated, and each identified fragment is marked with a letter corresponding to the schematic in (A).
https://doi.org/10.1371/journal.ppat.1013324.s005
(PDF)
S6 Fig. Plasmid verification in B. burgdorferi strains used in the study using whole-genome sequencing.
Fold change over mean chromosome read counts for each plasmid present in strains: A. B31 IR, B. K2, C. N40, and D. 297. For each strain, a fold change near 0 (< 0.25) indicates that it is missing that plasmid.
https://doi.org/10.1371/journal.ppat.1013324.s006
(PDF)
S7 Fig. N-acetylmuramyl-l-alanine amidase activity present in BSK-II and heat-inactivated rabbit serum.
BSK-II or heat-inactivated rabbit serum was incubated at 37ºC in the presence or absence of purified PGBb sacculi for 24 h prior to LC-MS. A. Schematic of N-acetylmuramyl-l-alanine amidase activity when mixed with purified PGBb. Cut sites by a N-acetylmuramyl-l-alanine amidase are shown by red curvy lines. B. Digestion in BSK-II. C. Digestion in heat-inactivated rabbit serum (100%). For B-C, plots show the extracted ion count (EIC) for the l-Ala-d-Glu-l-Orn(Gly), the predominant expected digestion product of PGBb sacculi by a N-acetylmuramyl-l-alanine amidase. For both panels, the bar shows the mean and the dots represent the data of two biological replicates of BSK-II media and rabbit sera sourced from different lot numbers.
https://doi.org/10.1371/journal.ppat.1013324.s007
(PDF)
S8 Fig. Structural prediction comparison between B. burgdorferi BB0605 and E. coli DacA. A.
Predicted structure of B. burgdorferi BB0605 using Foldseek [109]. B. Structure of E. coli DacA obtained from the Protein Data Bank (PDB) [110,111]. C. Alignment of BB0605 and DacA, performed using ChimeraX [112]. The root mean square deviation (RMSD) from alignment is presented, along with the alignment algorithm used.
https://doi.org/10.1371/journal.ppat.1013324.s008
(PDF)
S9 Fig. Assessment of MurNAc-containing PG species in culture supernatants of B. burgdorferi strain K2.
Plots showing the extracted ion counts of GlcNAc-MurNAc, GlcNAc-MurNAc-l-Ala-d-Glu-l-Orn(Gly), and GlcNAc-MurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala in culture supernatants (Sup) compared to medium alone (BSK).
https://doi.org/10.1371/journal.ppat.1013324.s009
(PDF)
S10 Fig. Structural prediction comparison between B. burgdorferi BB0259 and E. coli Slt70.
A. Predicted structure of BB0259 using Foldseek [109]. B. Structure of E. coli Slt70 obtained from the Protein Data Bank (PDB) [111,113]. C. Alignment of BB0259 and Slt70 using ChimeraX [112]. The root mean square deviation from alignment is presented, along with the alignment algorithm used.
https://doi.org/10.1371/journal.ppat.1013324.s010
(PDF)
S11 Fig. Stimulation of THP-1 and hNOD2 reporter cells.
A. Comparison between MurNAc-containing and AnhMurNAc-containing species in Fig 5A. The schematic of the PGBb species in each group is shown, along with a legend that defines each chemical moiety. Dots represent the means of each PGBb compound. Bar heights represent the means for each compound group. The groups were compared using a Welch’s t-test to account for different standard deviations and N values. B. Plot showing IL-8 production in differentiated THP-1 cells in the presence of the indicated PGBb fragments. The error bars represent standard deviation of the mean, and bar height represents the mean. Dots represent data from three biological replicates. C. Comparison of MurNAc-containing and AnhMurNAc-containing species in (B), including MDP as in (A). Dots represent the means of each PGBb compound. Bar heights represent the means for each compound group. The groups were compared using a Welch’s t-test to account for different standard deviations and N values. D. Dose-response curve of hNOD2 reporter cells to MDP in MilliQ H2O. The line connects the mean measurements of each concentration, and the dots represent technical replicates.
https://doi.org/10.1371/journal.ppat.1013324.s011
(PDF)
S12 Fig. Absence of detectable stimulation of hNod2 reporter cells by culture supernatants of various B. burgdorferi strains.
A. NOD2 data from Fig 5B with PGBb grouped based on the presence of a MurNAc or AnhMurNAc, as shown by the schematics and the legend. Dots represent the means of each PGBb compound. Bar heights represent the means for each compound group. The lines above the plot show pairwise comparisons between each group using Welch’s t-tests to account for different standard deviations and N values. The resulting p-values were adjusted using a Bonferonni correction for multiple comparisons. B. Plot showing the SEAP activity of hNOD2 reporter cells (used after fifth passage) following 16-h exposure to 1 µM MDP (positive control) compared to complete BSK-II medium (negative control), or supernatants of cultures in stationary phase for three days. Each dot is a technical replicate, and the height of each bar represents the mean.
https://doi.org/10.1371/journal.ppat.1013324.s012
(PDF)
S13 Fig. Ion count profiles of MurNAc- and AnhMurNAc-containing monomers in PGBb sacculi isolated from 10-day-old stationary phase cultures of B. burgdorferi.
PGBb sacculi were isolated from 10-day-old stationary phase cultures of B31 IR cells and digested with mutanolysin. Digest products were then analyzed by LC-MS. A. Extracted ion count profiles for GlcNAc-MurNAc-l-Ala-d-Glu-l-Orn(Gly) (blue) vs. GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly) (orange). B. Extracted ion count profiles for GlcNAc-MurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala (blue) vs. GlcNAc-AnhMurNAc-l-Ala-d-Glu-l-Orn(Gly)-d-Ala-d-Ala (orange).
https://doi.org/10.1371/journal.ppat.1013324.s013
(PDF)
S14 Fig. Patient joint fluid and serum digestions of purified PGBb sacculi.
This heatmap is similar to Fig 6A except that negative control are samples in which no sacculi were added. Samples were incubated with MilliQ H2O (- PGBb sacculi) or with PGBb sacculi (+ PGBb sacculi) for 6 h, then the resulting reaction products were analyzed by LC-MS. PGBb species were detected by their predicted [M+H] value (S1 Dataset). All samples were derived from Lyme arthritis patients whose identities (IDs) are color-coded as in Fig 6A. The accompanying table contains the key to interpret the PGBb fragment species in the heatmap. B. Representative extracted ion counts for peptide or sugar-peptide conjugate digestion products in serum and joint fluid samples predicted based on their masses. Each dot was derived from integrating the relevant EIC peak. These are the same fragments and analysis as in Fig 6B, but with a linear scale on the y-axis.
https://doi.org/10.1371/journal.ppat.1013324.s014
(PDF)
S1 Table. Common PG species referenced within this manuscript.
The letter key refers to the heatmap table in Fig 6A. The peptidoglycan fragment masses were generated by summing the masses of each individual subunit and subtracting the mass of water with each addition.
https://doi.org/10.1371/journal.ppat.1013324.s015
(PDF)
S2 Table. B. burgdorferi strains used in this study.
https://doi.org/10.1371/journal.ppat.1013324.s016
(PDF)
S3 Table.
The LC gradient for LC-MS experiments. Buffers A and B are noted in Materials and Methods.
https://doi.org/10.1371/journal.ppat.1013324.s017
(PDF)
S1 Dataset.
Theoretical masses for monomeric and dimeric species of B. burgdorferi peptidoglycan. A mass library representing all permutations of possible B. burgdorferi peptidoglycan monomers and dimers was computationally generated by adding the mass of individual amino acid and saccharides and subtracting a water mass (18.0105647) for each addition. Each addition or subtraction of one proton used the mass of hydrogen (1.007276), and the mass of the sodium adduct corresponds to 22.98976928. See the tab “Muropeptide_letter_key” for a letter definition of the name listed in the “species” column.
https://doi.org/10.1371/journal.ppat.1013324.s018
(XLSX)
Acknowledgments
We would like to thank Drs. Jonathon Z. Long, Veronica L. Li, Yuqin Dai, and Mengying Fu for their guidance on the mass spectrometry experiments. We also thank the Nucleus at the Stanford Sarafan ChEM-H insititute for access to mass spectrometry equipment. We are also grateful to the Jacobs-Wagner Laboratory for support, discussion, and critical reading of the manuscript. We would also like to thank the members of the Rego and Bockenstedt laboratories at Yale School of Medicine for providing lab space, equipment, and expertise to Z.A.K. to facilitate this work. Portions of this work were originally part of the dissertation of one of the co-first authors (Z.A.K.).
References
- 1. Mead PS. Epidemiology of Lyme Disease. Inf Dis Clin North America. 2015;29(2):187–219. pmid:25999219
- 2. Mead PS, Schwartz A. Epidemiology of lyme disease. In: Radolf JD, Samuels DS, ed. Lyme disease and relapsing fever spirochetes: genomics, molecular biology, host interactions and disease pathogenesis. Caister Academic Press; 2021.
- 3. Kugeler KJ, Earley A, Mead PS, Hinckley AF. Surveillance for lyme disease after implementation of a revised case definition - United States, 2022. MMWR Morb Mortal Wkly Rep. 2024;73(6):118–23. pmid:38358952
- 4. Pustijanac E, Buršić M, Millotti G, Paliaga P, Iveša N, Cvek M. Tick-borne bacterial diseases in Europe: threats to public health. Eur J Clin Microbiol Infect Dis. 2024;43(7):1261–95. pmid:38676855
- 5. Radolf JD, Caimano MJ, Stevenson B, Hu LT. Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol. 2012;10(2):87–99. pmid:22230951
- 6. Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am. 2015;29(2):269–80. pmid:25999223
- 7. Lochhead RB, Strle K, Arvikar SL, Weis JJ, Steere AC. Lyme arthritis: linking infection, inflammation and autoimmunity. Nat Rev Rheumatol. 2021;17(8):449–61. pmid:34226730
- 8. Jutras BL, Lochhead RB, Kloos ZA, Biboy J, Strle K, Booth CJ, et al. Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis. Proc Natl Acad Sci U S A. 2019;116(27):13498–507. pmid:31209025
- 9. Wolf AJ, Underhill DM. Peptidoglycan recognition by the innate immune system. Nat Rev Immunol. 2018;18(4):243–54. pmid:29292393
- 10. Beck G, Benach JL, Habicht GS. Isolation, preliminary chemical characterization, and biological activity of Borrelia burgdorferi peptidoglycan. Biochem Biophys Res Commun. 1990;167(1):89–95. pmid:2310405
- 11. Lochhead RB, Arvikar SL, Aversa JM, Sadreyev RI, Strle K, Steere AC. Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with postinfectious, Borrelia burgdorferi-induced Lyme arthritis. Cell Microbiol. 2019;21(2):e12954. pmid:30218476
- 12. Petnicki-Ocwieja T, DeFrancesco AS, Chung E, Darcy CT, Bronson RT, Kobayashi KS, et al. Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance. PLoS One. 2011;6(2):e17414. pmid:21387014
- 13. Oosting M, Berende A, Sturm P, Ter Hofstede HJM, de Jong DJ, Kanneganti T-D, et al. Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction. J Infect Dis. 2010;201(12):1849–58. pmid:20441518
- 14. Rouse JR, Danner R, Wahhab A, Pereckas M, Nguyen C, McClune ME, et al. HLA-DR-expressing fibroblast-like Synoviocytes are inducible antigen presenting cells that present autoantigens in Lyme arthritis. ACR Open Rheumatol. 2024;6(10):678–89. pmid:39073021
- 15. Park JT, Uehara T. How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol Mol Biol Rev. 2008;72(2):211–27. pmid:18535144
- 16. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature. 1997;390(6660):580–6. pmid:9403685
- 17. Rego ROM, Bestor A, Rosa PA. Defining the plasmid-borne restriction-modification systems of the Lyme disease spirochete Borrelia burgdorferi. J Bacteriol. 2011;193(5):1161–71. pmid:21193609
- 18. Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, et al. The spirochetal etiology of Lyme disease. N Engl J Med. 1983;308(13):733–40. pmid:6828118
- 19. Barthold SW, Moody KD, Terwilliger GA, Duray PH, Jacoby RO, Steere AC. Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis. 1988;157(4):842–6. pmid:3258003
- 20. Casjens SR, Mongodin EF, Qiu W-G, Luft BJ, Schutzer SE, Gilcrease EB, et al. Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids. PLoS One. 2012;7(3):e33280. pmid:22432010
- 21. Hillman C, Theriault H, Dmitriev A, Hansra S, Rosa PA, Wachter J. Borrelia burgdorferi lacking all cp32 prophage plasmids retains full infectivity in mice. EMBO Rep. 2025;26(8):1997–2012. pmid:40108404
- 22. Valinger Z, Ladesić B, Tomasić J. Partial purification and characterization of N-acetylmuramyl-L-alanine amidase from human and mouse serum. Biochim Biophys Acta. 1982;701(1):63–71. pmid:6120007
- 23. de Pedro MA, Cava F. Structural constraints and dynamics of bacterial cell wall architecture. Front Microbiol. 2015;6:449. pmid:26005443
- 24. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev. 2008;32(2):234–58. pmid:18266856
- 25. Lin T, Gao L, Zhang C, Odeh E, Jacobs MB, Coutte L, et al. Analysis of an ordered, comprehensive STM mutant library in infectious Borrelia burgdorferi: insights into the genes required for mouse infectivity. PLoS One. 2012;7(10):e47532. pmid:23133514
- 26. Ghosh AS, Young KD. Sequences near the active site in chimeric penicillin binding proteins 5 and 6 affect uniform morphology of Escherichia coli. J Bacteriol. 2003;185(7):2178–86. pmid:12644487
- 27. Jutras BL, Scott M, Parry B, Biboy J, Gray J, Vollmer W, et al. Lyme disease and relapsing fever Borrelia elongate through zones of peptidoglycan synthesis that mark division sites of daughter cells. Proc Natl Acad Sci U S A. 2016;113(33):9162–70. pmid:27506799
- 28. Höltje JV, Mirelman D, Sharon N, Schwarz U. Novel type of murein transglycosylase in Escherichia coli. J Bacteriol. 1975;124(3):1067–76. pmid:357
- 29. Kraft AR, Templin MF, Höltje JV. Membrane-bound lytic endotransglycosylase in Escherichia coli. J Bacteriol. 1998;180(13):3441–7. pmid:9642199
- 30. Taylor A, Das BC, Heijenoort J. Bacterial-cell-wall peptidoglycan fragments produced by phage λ or Vi II endolysin and containing 1,6-anhydro-N-acetylmuramic acid. Eur J Biochem. 1975;53(1):47–54.
- 31. Dik DA, Marous DR, Fisher JF, Mobashery S. Lytic transglycosylases: concinnity in concision of the bacterial cell wall. Crit Rev Biochem Mol Biol. 2017;52(5):503–42. pmid:28644060
- 32. Bohrhunter JL, Rohs PDA, Torres G, Yunck R, Bernhardt TG. MltG activity antagonizes cell wall synthesis by both types of peptidoglycan polymerases in Escherichia coli. Mol Microbiol. 2021;115(6):1170–80. pmid:33278861
- 33. Yunck R, Cho H, Bernhardt TG. Identification of MltG as a potential terminase for peptidoglycan polymerization in bacteria. Mol Microbiol. 2016;99(4):700–18. pmid:26507882
- 34. Sassine J, Pazos M, Breukink E, Vollmer W. Lytic transglycosylase MltG cleaves in nascent peptidoglycan and produces short glycan strands. Cell Surf. 2021;7:100053. pmid:34036206
- 35. Weaver AI, Alvarez L, Rosch KM, Ahmed A, Wang GS, van Nieuwenhze MS, et al. Lytic transglycosylases mitigate periplasmic crowding by degrading soluble cell wall turnover products. Elife. 2022;11:e73178. pmid:35073258
- 36. Xu H, Hu B, Flesher DA, Liu J, Motaleb MA. BB0259 encompasses a peptidoglycan lytic enzyme function for proper assembly of periplasmic flagella in Borrelia burgdorferi. Front Microbiol. 2021;12:692707. pmid:34659138
- 37. Toledo A, Huang Z, Coleman JL, London E, Benach JL. Lipid rafts can form in the inner and outer membranes of Borrelia burgdorferi and have different properties and associated proteins. Mol Microbiol. 2018;108(1):63–76. pmid:29377398
- 38. Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, Guadagnini S, et al. Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog. 2006;2(9):e97. pmid:17002496
- 39. Knilans KJ, Hackett KT, Anderson JE, Weng C, Dillard JP, Duncan JA. Neisseria gonorrhoeae lytic Transglycosylases LtgA and LtgD reduce host innate immune signaling through TLR2 and NOD2. ACS Infect Dis. 2017;3(9):624–33. pmid:28585815
- 40. Harris-Jones TN, Chan JM, Hackett KT, Weyand NJ, Schaub RE, Dillard JP. Peptidoglycan fragment release and NOD activation by commensal Neisseria species from humans and other animals. Infect Immun. 2024;92(5):e0000424. pmid:38563734
- 41. Putnik R, Zhou J, Irnov I, Garner E, Liu M, Bersch KL, et al. Synthesis of a Borrelia burgdorferi-derived muropeptide standard fragment library. Molecules. 2024;29(14):3297. pmid:39064876
- 42. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem. 2003;278(8):5509–12. pmid:12514169
- 43. Mo J, Boyle JP, Howard CB, Monie TP, Davis BK, Duncan JA. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. J Biol Chem. 2012;287(27):23057–67. pmid:22549783
- 44. Jakopin Ž, Corsini E. THP-1 cells and pro-inflammatory cytokine production: an in vitro tool for functional characterization of NOD1/NOD2 antagonists. Int J Mol Sci. 2019;20(17):4265. pmid:31480368
- 45. Hasegawa M, Yang K, Hashimoto M, Park J-H, Kim Y-G, Fujimoto Y, et al. Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments. J Biol Chem. 2006;281(39):29054–63. pmid:16870615
- 46. Wang G, Iyer R, Bittker S, Cooper D, Small J, Wormser GP, et al. Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect Immun. 2004;72(11):6702–6. pmid:15501807
- 47. Yang X, Popova TG, Goldberg MS, Norgard MV. Influence of cultivation media on genetic regulatory patterns in Borrelia burgdorferi. Infect Immun. 2001;69(6):4159–63. pmid:11349092
- 48. Callister SM, Case KL, Agger WA, Schell RF, Johnson RC, Ellingson JL. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J Clin Microbiol. 1990;28(2):363–5. pmid:2179264
- 49. Zhang J, Takacs CN, McCausland JW, Mueller EA, Buron J, Thappeta Y, et al. Borrelia burgdorferi loses essential genetic elements and cell proliferative potential during stationary phase in culture but not in the tick vector. J Bacteriol. 2025;207(3):e0045724. pmid:39950812
- 50. Dziarski R, Gupta D. Review: mammalian peptidoglycan recognition proteins (PGRPs) in innate immunity. Innate Immun. 2010;16(3):168–74. pmid:20418257
- 51. Vanderwinkel E, de Pauw P, Philipp D, Ten Have JP, Bainter K. The human and mammalian N-acetylmuramyl-L-alanine amidase: distribution, action on different bacterial peptidoglycans, and comparison with the human lysozyme activities. Biochem Mol Med. 1995;54(1):26–32. pmid:7551813
- 52. Vollmer W, Blanot D, de Pedro MA. Peptidoglycan structure and architecture. FEMS Microbiol Rev. 2008;32(2):149–67. pmid:18194336
- 53. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol. 2003;4(7):702–7. pmid:12796777
- 54. Girardin SE, Travassos LH, Hervé M, Blanot D, Boneca IG, Philpott DJ, et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem. 2003;278(43):41702–8. pmid:12871942
- 55. Stafford CA, Gassauer A-M, de Oliveira Mann CC, Tanzer MC, Fessler E, Wefers B, et al. Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation. Nature. 2022;609(7927):590–6. pmid:36002575
- 56. Jacobs C, Huang LJ, Bartowsky E, Normark S, Park JT. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta-lactamase induction. EMBO J. 1994;13(19):4684–94. pmid:7925310
- 57. Irazoki O, Hernandez SB, Cava F. Peptidoglycan muropeptides: release, perception, and functions as signaling molecules. Front Microbiol. 2019;10:500. pmid:30984120
- 58. Dworkin J. The medium is the message: interspecies and interkingdom signaling by peptidoglycan and related bacterial glycans. Annu Rev Microbiol. 2014;68:137–54. pmid:24847956
- 59. Koropatnick TA, Engle JT, Apicella MA, Stabb EV, Goldman WE, McFall-Ngai MJ. Microbial factor-mediated development in a host-bacterial mutualism. Science. 2004;306(5699):1186–8. pmid:15539604
- 60. Sultan SZ, Manne A, Stewart PE, Bestor A, Rosa PA, Charon NW, et al. Motility is crucial for the infectious life cycle of Borrelia burgdorferi. Infect Immun. 2013;81(6):2012–21. pmid:23529620
- 61. Sultan SZ, Sekar P, Zhao X, Manne A, Liu J, Wooten RM, et al. Motor rotation is essential for the formation of the periplasmic flagellar ribbon, cellular morphology, and Borrelia burgdorferi persistence within Ixodes scapularis tick and murine hosts. Infect Immun. 2015;83(5):1765–77. pmid:25690096
- 62. Li C, Xu H, Zhang K, Liang FT. Inactivation of a putative flagellar motor switch protein FliG1 prevents Borrelia burgdorferi from swimming in highly viscous media and blocks its infectivity. Mol Microbiol. 2010;75(6):1563–76. pmid:20180908
- 63. Cheng Q, Park JT. Substrate specificity of the AmpG permease required for recycling of cell wall anhydro-muropeptides. J Bacteriol. 2002;184(23):6434–6. pmid:12426329
- 64. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med. 1984;57(4):521–5. pmid:6393604
- 65. DeHart TG, Kushelman MR, Hildreth SB, Helm RF, Jutras BL. The unusual cell wall of the Lyme disease spirochaete Borrelia burgdorferi is shaped by a tick sugar. Nat Microbiol. 2021;6(12):1583–92. pmid:34819646
- 66. Rhodes RG, Atoyan JA, Nelson DR. The chitobiose transporter, chbC, is required for chitin utilization in Borrelia burgdorferi. BMC Microbiol. 2010;10:21. pmid:20102636
- 67. Li X, McHugh GA, Damle N, Sikand VK, Glickstein L, Steere AC. Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis. Arthritis Rheum. 2011;63(8):2238–47. pmid:21590753
- 68. Kannian P, McHugh G, Johnson BJB, Bacon RM, Glickstein LJ, Steere AC. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis. Arthritis Rheum. 2007;56(12):4216–25. pmid:18050219
- 69. Steere AC, Hardin JA, Ruddy S, Mummaw JG, Malawista SE. Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum. 1979;22(5):471–83. pmid:109097
- 70. Dalldorf FG, Cromartie WJ, Anderle SK, Clark RL, Schwab JH. The relation of experimental arthritis to the distribution of streptococcal cell wall fragments. Am J Pathol. 1980;100(2):383–402. pmid:6996490
- 71. Cromartie WJ, Craddock JG, Schwab JH, Anderle SK, Yang CH. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med. 1977;146. pmid:336836
- 72. McClune ME, Ebohon O, Dressler JM, Davis MM, Tupik JD, Lochhead RB, et al. The peptidoglycan of Borrelia burgdorferi can persist in discrete tissues and cause systemic responses consistent with chronic illness. Sci Transl Med. 2025;17(795):eadr2955. pmid:40267217
- 73. Jeyaraman M, Jeyaraman N, Ramasubramanian S, Balaji S, Muthu S. Evidence-based orthobiologic practice: current evidence review and future directions. World J Orthop. 2024;15(10):908–17. pmid:39473516
- 74. Beitzel K, Allen D, Apostolakos J, Russell RP, McCarthy MB, Gallo GJ, et al. US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine. J Knee Surg. 2015;28(1):29–34. pmid:25268794
- 75. Schrijver IA, Melief MJ, Tak PP, Hazenberg MP, Laman JD. Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. Arthritis Rheum. 2000;43(10):2160–8. pmid:11037875
- 76. Schrijver IA, Melief MJ, Markusse HM, Van Aelst I, Opdenakker G, Hazenberg MP, et al. Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects. Rheumatology (Oxford). 2001;40(4):438–46. pmid:11312384
- 77. Holub MN, Wahhab A, Rouse JR, Danner R, Hackner LG, Duris CB, et al. Peptidoglycan in osteoarthritis synovial tissue is associated with joint inflammation. Arthritis Res Ther. 2024;26(1):77. pmid:38532447
- 78. Clowers JS, Allensworth JJ, Lee EJ, Rosenzweig HL. Investigation of the peptidoglycan sensing molecule, PGLYRP-2, in murine inflammatory uveitis. Br J Ophthalmol. 2013;97(4):504–10. pmid:23361435
- 79. Zückert W. Laboratory maintenance of Borrelia burgdorferi. Current Protocol Microbiol. pmid:18770608
- 80. Jutras BL, Chenail AM, Stevenson B. Changes in bacterial growth rate govern expression of the Borrelia burgdorferi OspC and Erp infection-associated surface proteins. J Bacteriol. 2013;195(4):757–64. pmid:23222718
- 81. Takacs CN, Kloos ZA, Scott M, Rosa PA, Jacobs-Wagner C. Fluorescent proteins, promoters, and selectable markers for applications in the lyme disease spirochete Borrelia burgdorferi. Appl Environ Microbiol. 2018;84(24):e01824-18. pmid:30315081
- 82. Bono JL, Elias AF, Kupko JJ 3rd, Stevenson B, Tilly K, Rosa P. Efficient targeted mutagenesis in Borrelia burgdorferi. J Bacteriol. 2000;182(9):2445–52. pmid:10762244
- 83. Elias AF, Bono JL, Kupko JJ 3rd, Stewart PE, Krum JG, Rosa PA. New antibiotic resistance cassettes suitable for genetic studies in Borrelia burgdorferi. J Mol Microbiol Biotechnol. 2003;6(1):29–40. pmid:14593251
- 84. Frank KL, Bundle SF, Kresge ME, Eggers CH, Samuels DS. aadA confers streptomycin resistance in Borrelia burgdorferi. J Bacteriol. 2003;185(22):6723–7. pmid:14594849
- 85. Tatusova T, Ciufo S, Fedorov B, O’Neill K, Tolstoy I. RefSeq microbial genomes database: new representation and annotation strategy. Nucleic Acids Res. 2014;42(Database issue):D553–9. pmid:24316578
- 86. Schutzer SE, Fraser-Liggett CM, Casjens SR, Qiu W-G, Dunn JJ, Mongodin EF, et al. Whole-genome sequences of thirteen isolates of Borrelia burgdorferi. J Bacteriol. 2011;193(4):1018–20. pmid:20935092
- 87.
Deatherage DE, Barrick JE. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. In: Sun L, Shou W, ed. Engineering and analyzing multicellular systems. New York, NY: Humana Press; 2014. 165–88.
- 88. Putri GH, Anders S, Pyl PT, Pimanda JE, Zanini F. Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinformatics. 2022;38(10):2943–5. pmid:35561197
- 89. Alvarez L, Hernandez SB, de Pedro MA, Cava F. Ultra-sensitive, high-resolution liquid chromatography methods for the high-throughput quantitative analysis of bacterial cell wall chemistry and structure. Methods Mol Biol. 2016;1440:11–27. pmid:27311661
- 90. Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neumann S, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol. 2012;30(10):918–20. pmid:23051804
- 91. Bald T, Barth J, Niehues A, Specht M, Hippler M, Fufezan C. pymzML--Python module for high-throughput bioinformatics on mass spectrometry data. Bioinformatics. 2012;28(7):1052–3. pmid:22302572
- 92. Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78(3):779–87. pmid:16448051
- 93. Gatto L, Gibb S, Rainer J. MSnbase, efficient and elegant R-based processing and visualization of raw mass spectrometry data. J Proteome Res. 2021;20(1):1063–9. pmid:32902283
- 94. Rainer J, Vicini A, Salzer L, Stanstrup J, Badia JM, Neumann S, et al. A modular and expandable ecosystem for metabolomics data annotation in R. Metabolites. 2022;12(2):173. pmid:35208247
- 95. Harris CR, Millman KJ, van der Walt SJ, Gommers R, Virtanen P, Cournapeau D, et al. Array programming with NumPy. Nature. 2020;585(7825):357–62. pmid:32939066
- 96. McKinney W. Pandas: a foundational python library for data analysis and statistics. 2011.
- 97. Glaser P, Sharpe ME, Raether B, Perego M, Ohlsen K, Errington J. Dynamic, mitotic-like behavior of a bacterial protein required for accurate chromosome partitioning. Genes Dev. 1997;11(9):1160–8. pmid:9159397
- 98. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. pmid:22743772
- 99. Mäkelä J, Papagiannakis A, Lin W-H, Lanz MC, Glenn S, Swaffer M, et al. Genome concentration limits cell growth and modulates proteome composition in Escherichia coli. Elife. 2024;13:RP97465. pmid:39714909
- 100. Papagiannakis A, Yu Q, Govers SK, Lin W-H, Wingreen NS, Jacobs-Wagner C. Nonequilibrium polysome dynamics promote chromosome segregation and its coupling to cell growth in Escherichia coli. Elife. 2025;14:RP104276. pmid:40552714
- 101. Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17(3):261–72. pmid:32015543
- 102. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR Recomm Rep. 1990;39(RR-13):1–43. pmid:2122225
- 103. Lantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, et al. Clinical practice guidelines by the infectious diseases society of America, American academy of neurology, and American college of rheumatology: 2020 guidelines for the prevention, diagnosis, and treatment of lyme disease. Neurology. 2021;96(6):262–73. pmid:33257476
- 104. Lochhead RB, Strle K, Kim ND, Kohler MJ, Arvikar SL, Aversa JM, et al. MicroRNA expression shows inflammatory dysregulation and tumor-like proliferative responses in joints of patients with postinfectious lyme arthritis. Arthritis Rheumatol. 2017;69(5):1100–10. pmid:28076897
- 105. van der Walt S, Schönberger JL, Nunez-Iglesias J, Boulogne F, Warner JD, Yager N, et al. Scikit-image: image processing in Python. PeerJ. 2014;2:e453. pmid:25024921
- 106. Waskom M. seaborn: statistical data visualization. JOSS. 2021;6(60):3021.
- 107. Watanabe Y, Aoki-Kinoshita KF, Ishihama Y, Okuda S. GlycoPOST realizes FAIR principles for glycomics mass spectrometry data. Nucleic Acids Res. 2021;49(D1):D1523–8. pmid:33174597
- 108. Hartley M, Kleywegt GJ, Patwardhan A, Sarkans U, Swedlow JR, Brazma A. The BioImage archive - building a home for life-sciences microscopy data. J Mol Biol. 2022;434(11):167505. pmid:35189131
- 109. van Kempen M, Kim SS, Tumescheit C, Mirdita M, Lee J, Gilchrist CLM, et al. Fast and accurate protein structure search with Foldseek. Nat Biotechnol. 2024;42(2):243–6. pmid:37156916
- 110. Nicholas RA, Krings S, Tomberg J, Nicola G, Davies C. Crystal structure of wild-type penicillin-binding protein 5 from Escherichia coli: implications for deacylation of the acyl-enzyme complex. J Biol Chem. 2003;278(52):52826–33. pmid:14555648
- 111. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235–42. pmid:10592235
- 112. Meng EC, Goddard TD, Pettersen EF, Couch GS, Pearson ZJ, Morris JH, et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 2023;32(11):e4792. pmid:37774136
- 113. van Asselt EJ, Thunnissen AM, Dijkstra BW. High resolution crystal structures of the Escherichia coli lytic transglycosylase Slt70 and its complex with a peptidoglycan fragment. J Mol Biol. 1999;291(4):877–98. pmid:10452894